{"gene":"ARHGEF2","run_date":"2026-06-14T07:33:11","timeline":{"discoveries":[{"year":1995,"finding":"Lfc (ARHGEF2) was identified as an oncoprotein containing a Dbl homology (DH) domain in tandem with a pleckstrin homology (PH) domain; deletion analysis showed both PH and DH domains are required for NIH 3T3 transformation, with the PH domain mediating membrane recruitment necessary for transforming activity.","method":"Retroviral cDNA transfer, NIH 3T3 transformation assay, NH2- and COOH-terminal deletion analysis, isoprenylation site replacement","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct mutagenesis/deletion analysis with functional readout (transformation), replicated by domain replacement","pmids":["7629163"],"is_preprint":false},{"year":1996,"finding":"Lfc (ARHGEF2) functions as a highly specific guanine nucleotide exchange factor for RhoA in vitro, catalytically stimulating >10-fold GDP dissociation from RhoA; it forms tight complexes with nucleotide-depleted RhoA and, uniquely, also binds Rac (but not Cdc42 or Ras), distinguishing it from other Dbl-family GEFs.","method":"In vitro [3H]GDP dissociation assay, GDP-[35S]GTPγS exchange assay, biochemical pulldown/complex formation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro GEF activity with catalytic demonstration, multiple substrates tested with rigorous controls","pmids":["8910315"],"is_preprint":false},{"year":1998,"finding":"GEF-H1 (ARHGEF2) stimulates guanine nucleotide exchange on Rac and Rho but not Cdc42, TC10, or Ras; it colocalizes with microtubules through its carboxyl-terminal coiled-coil domain, and overexpression in COS-7 cells induces membrane ruffles.","method":"In vitro GEF assay, immunofluorescence colocalization, domain analysis, COS-7 overexpression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro biochemical assay with substrate specificity profiling plus direct localization experiment","pmids":["9857026"],"is_preprint":false},{"year":1999,"finding":"Lfc (ARHGEF2) localizes to microtubules via its PH domain interaction with tubulin; overexpression in NIH 3T3 cells induces actin stress fibers and membrane ruffles consistent with RhoA and Rac1 activation, and Lfc stimulates JNK activity in a Rac1-dependent (and partially RhoA-dependent) manner.","method":"Immunofluorescence localization, dominant-negative GTPase epistasis, JNK activity assay, GTP-bound Rac measurement","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (localization, epistasis with dominant negatives, kinase assay) in a single study","pmids":["9890991"],"is_preprint":false},{"year":2002,"finding":"GEF-H1 (ARHGEF2) is regulated by microtubule binding: GEF-H1 mutants deficient in microtubule binding have higher RhoA GEF activity, and drug-induced microtubule depolymerization phenocopies active GEF-H1 expression in a dominant-negative GEF-H1-inhibitable manner, establishing that microtubule-bound GEF-H1 is in an inactive state.","method":"Microtubule-binding mutant analysis, nocodazole treatment, dominant-negative GEF-H1 expression, morphology/actin organization assay, gene expression analysis","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — mutant analysis plus pharmacological perturbation plus dominant-negative epistasis, replicated across multiple readouts","pmids":["11912491"],"is_preprint":false},{"year":2004,"finding":"PAK1 phosphorylates GEF-H1 at Ser885 (within the carboxyl-terminal inhibitory region), inducing 14-3-3 binding to GEF-H1 and relocation of 14-3-3 to microtubules; the carboxyl-terminal coiled-coil region of GEF-H1 is required for microtubule-dependent suppression of its GEF activity.","method":"Affinity-based kinase screen, in vitro phosphorylation assay, site-directed mutagenesis, Co-IP/pulldown for 14-3-3 binding, immunofluorescence","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro phosphorylation with mutagenesis identifying specific residue, protein interaction validated by Co-IP","pmids":["14970201"],"is_preprint":false},{"year":2004,"finding":"EPEC effectors EspG and Orf3 interact with tubulin and destabilize microtubules in vitro, thereby releasing GEF-H1 and activating RhoA-ROCK signaling to induce actin stress fibers; dominant-negative GEF-H1 and dominant-negative RhoA (but not Rac1/Cdc42) block EspG/Orf3-induced stress fiber formation.","method":"In vitro microtubule destabilization assay, dominant-negative epistasis, ROCK inhibitor treatment, bacterial infection assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro biochemical assay combined with genetic epistasis using dominant-negative constructs","pmids":["15318166"],"is_preprint":false},{"year":2005,"finding":"PAK4 directly associates with GEF-H1 through a novel GEF-H1 interaction domain (GID) in PAK4 and phosphorylates GEF-H1 at Ser810, blocking stress fiber formation while promoting lamellipodia; the endogenous PAK4–GEF-H1 complex associates with microtubules, and PAK4 phosphorylation releases GEF-H1 into the cytoplasm.","method":"Co-IP, in vitro phosphorylation, domain mapping, siRNA knockdown, immunofluorescence in NIH-3T3 cells","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro kinase assay with site identification, reciprocal Co-IP, and functional cellular phenotype","pmids":["15827085"],"is_preprint":false},{"year":2005,"finding":"GEF-H1 (Lfc/ARHGEF2) directly interacts with cingulin (a tight-junction adaptor protein); cingulin binding inhibits GEF-H1 RhoA GEF activity, providing a mechanism by which tight junction formation downregulates RhoA and inhibits G1/S cell cycle progression.","method":"Direct binding assay, RNAi knockdown, RhoA activation assay, G1/S phase transition assay in MDCK cells","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct protein interaction with functional GEF inhibition readout plus RNAi epistasis with cell cycle phenotype","pmids":["15866167"],"is_preprint":false},{"year":2005,"finding":"Lfc (ARHGEF2) interacts with neurabin and spinophilin via its coiled-coil domain; upon neuronal stimulation, Lfc translocates from dendritic shafts (where it associates with microtubules) to spines, reducing spine length and size through RhoA in a coiled-coil-dependent manner.","method":"Yeast two-hybrid, Co-IP, immunofluorescence/live imaging in neurons, domain deletion analysis","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — yeast two-hybrid validated by Co-IP, live-cell localization with functional spine morphology readout","pmids":["15996550"],"is_preprint":false},{"year":2005,"finding":"Lfc (ARHGEF2) is required for mitotic spindle assembly during prophase/prometaphase; inhibition of Lfc causes spindle defects and mitotic delay, rescued by constitutively active RhoA, placing Lfc upstream of RhoA in a pathway involving mDia1 for spindle formation.","method":"Antibody microinjection/dominant-negative, RhoA rescue epistasis, live-cell microscopy, cell cycle analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with RhoA rescue, multiple approaches (inhibition, rescue, dominant-negative), specific cellular phenotype","pmids":["15976019"],"is_preprint":false},{"year":2006,"finding":"Mutant p53 proteins (V157F, R175H, R248Q) transcriptionally activate GEF-H1 expression, leading to RhoA activation and accelerated tumor cell proliferation; growth of mutant p53 cells depends on GEF-H1 expression whereas wild-type p53 cells do not.","method":"Inducible mutant p53 cell lines, expression profiling, RhoA activation assay, siRNA knockdown, cell growth assay","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — expression profiling plus RhoA activation and knockdown phenotype, single lab","pmids":["16778209"],"is_preprint":false},{"year":2006,"finding":"TRIF-dependent (but not MyD88-dependent) LPS signaling in dendritic cells activates GEF-H1, which in turn activates RhoB (but not RhoA, Rac, or Cdc42); GEF-H1–RhoB drives surface MHCII expression required for CD4+ T cell activation.","method":"RNAi knockdown, dominant-negative constructs, Rho activation assays (pull-down), immunofluorescence colocalization, MyD88/TRIF knockout DCs","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout of adaptor proteins, siRNA, dominant-negative epistasis, specific GTPase activity assays with multiple orthogonal approaches","pmids":["16917499"],"is_preprint":false},{"year":2007,"finding":"GEF-H1 localizes to the mitotic apparatus (cortical microtubule tips and midbody); Aurora A/B and Cdk1/Cyclin B phosphorylate GEF-H1, inhibiting its catalytic activity during mitosis; dephosphorylation before cytokinesis allows GEF-H1-dependent RhoA GTP-loading at the cleavage furrow, distinct from Ect2-dependent Rho activation.","method":"Immunofluorescence localization, in vitro kinase assay (Aurora A/B, Cdk1/Cyclin B), live-cell RhoA biosensor (FRET), siRNA knockdown, GEF-H1 catalytic activity assay","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay identifying writers plus live-cell FRET biosensor for spatiotemporal RhoA activation, multiple orthogonal methods","pmids":["17488622"],"is_preprint":false},{"year":2008,"finding":"GEF-H1 is required and sufficient to mediate nocodazole-induced RhoA activation and cell contractility; siRNA depletion of GEF-H1 prevents nocodazole-induced RhoA activation, ROCK activation, MLC phosphorylation, and cell contraction, rescued by siRNA-resistant GEF-H1 re-expression.","method":"siRNA knockdown, rescue with siRNA-resistant GEF-H1, RhoA and ROCK activity assays, MLC phosphorylation western blot, nocodazole treatment","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — siRNA with specific rescue, multiple biochemical readouts of pathway activation","pmids":["18287519"],"is_preprint":false},{"year":2008,"finding":"ERK1/2 phosphorylate GEF-H1 at Thr678, enhancing its guanine nucleotide exchange activity toward RhoA; ERK pathway inhibition (PD184352) abolishes this phosphorylation.","method":"In vitro ERK1/2 phosphorylation assay, site-directed mutagenesis (Thr678), GEF activity assay, pharmacological ERK inhibition","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with mutagenesis identifying specific residue and functional GEF activity readout, single lab","pmids":["18211802"],"is_preprint":false},{"year":2008,"finding":"GEF-H1 interacts with NOD1 and is required for RIP2-dependent NF-κB activation in response to Shigella effectors IpgB2 and OspB and the NOD1 ligand γTriDAP; GEF-H1 is also required for Shigella cell invasion via RhoA activation.","method":"Co-IP (GEF-H1–NOD1 interaction), siRNA knockdown, NF-κB reporter assay, bacterial invasion assay","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP validating protein interaction, siRNA epistasis with both NF-κB and invasion readouts","pmids":["19043560"],"is_preprint":false},{"year":2009,"finding":"Lfc (ARHGEF2) localizes to the Golgi apparatus and growth cones in developing neurons and negatively regulates neurite sprouting and axon formation via RhoA; Tctex-1 (dynein light chain) physically interacts with Lfc, inhibiting its GEF activity, decreasing Rho-GTP, and antagonizing Lfc during neurite formation.","method":"Immunofluorescence, Co-IP (Lfc–Tctex-1), RhoA activity assay, siRNA knockdown, axon formation assay","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP validating physical interaction, RhoA activity assay, siRNA knockdown with specific axon phenotype","pmids":["20463241"],"is_preprint":false},{"year":2009,"finding":"Lfc (ARHGEF2) and its negative regulator Tctex-1 determine the balance between proliferative symmetric and neurogenic asymmetric divisions of cortical radial precursors; Lfc knockdown maintains cells as cycling radial precursors while Tctex-1 knockdown promotes neurogenesis; the two proteins regulate mitotic spindle orientation.","method":"Morpholino/siRNA knockdown in cortical precursors in vitro and in vivo, lineage tracing, spindle orientation analysis","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo knockdown with coincident double-knockdown epistasis, specific mitotic spindle orientation phenotype","pmids":["19448628"],"is_preprint":false},{"year":2009,"finding":"PKA phosphorylates Lfc (ARHGEF2) in an AKAP121-dependent manner; this phosphorylation promotes 14-3-3 binding to Lfc in a phosphorylation-dependent manner and suppresses Lfc exchange activity on RhoA; Tctex-1 competes with 14-3-3 for Lfc binding.","method":"Co-IP (Lfc–AKAP121, Lfc–14-3-3), in vitro PKA phosphorylation, forskolin treatment, RhoA GEF activity assay, 14-3-3 binding mutant analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay, protein interaction by Co-IP, functional GEF assay with inhibitory readout, single lab","pmids":["19667072"],"is_preprint":false},{"year":2009,"finding":"GEF-H1 directly interacts with paracingulin (at epithelial junctions), and paracingulin depletion increases RhoA activity; paracingulin is required for efficient recruitment of GEF-H1 to junctions, linking junction assembly to RhoA regulation.","method":"In vitro binding assay, Co-IP, siRNA knockdown, RhoA activation pull-down, immunofluorescence","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vitro binding plus Co-IP plus siRNA with RhoA activity readout, multiple orthogonal methods","pmids":["18653465"],"is_preprint":false},{"year":2009,"finding":"GEF-H1 interacts with the Y-box transcription factor ZONAB/DbpA; GEF-H1 overexpression induces nuclear ZONAB accumulation and activates ZONAB-dependent transcription; GEF-H1 and ZONAB together are required for RhoA-dependent cyclin D1 expression.","method":"Co-IP (GEF-H1–ZONAB), overexpression, cyclin D1 promoter reporter, siRNA knockdown, immunofluorescence","journal":"EMBO reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus reporter assay and siRNA, single lab","pmids":["19730435"],"is_preprint":false},{"year":2009,"finding":"GEF-H1 is a component of the AMPA receptor complex in the brain; it is enriched in the postsynaptic density, colocalizes with GluR1 at spines, and negatively regulates spine density and length through RhoA; AMPA-R-dependent changes in spine morphology are abolished by GEF-H1 knockdown.","method":"Co-IP from brain lysate, immunofluorescence, siRNA knockdown, spine morphology analysis, RhoA activity assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP from native brain tissue, siRNA epistasis, direct spine morphology readout","pmids":["19208802"],"is_preprint":false},{"year":2009,"finding":"TNF-α activates GEF-H1 via ERK-mediated phosphorylation of Thr678 in tubular epithelial cells, leading to RhoA activation, MLC phosphorylation, and increased paracellular permeability; GEF-H1 was identified as a TNF-α-activated RhoGEF using a RhoG17A affinity precipitation/mass spectrometry approach.","method":"RhoG17A affinity precipitation/mass spectrometry, siRNA knockdown, MEK inhibitor, phospho-specific western blot, permeability assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — unbiased proteomics identification followed by siRNA epistasis and pharmacological pathway dissection with multiple readouts","pmids":["19261619"],"is_preprint":false},{"year":2010,"finding":"TGF-β transcriptionally upregulates GEF-H1 in a Smad4-dependent manner in RPE cells; GEF-H1 induction leads to RhoA activation and is required for TGF-β-induced α-SMA expression and cell migration.","method":"Genome-wide expression analysis, Smad4-dependent transcription assay, GEF-H1 siRNA knockdown, RhoA activity assay, cell migration assay","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide expression screen identifying GEF-H1 as unique RhoGEF upregulated, Smad4 dependence, siRNA epistasis with functional readouts","pmids":["20089843"],"is_preprint":false},{"year":2010,"finding":"Lfc (ARHGEF2) and p114-RhoGEF mediate Wnt-3a/Dishevelled-induced RhoA activation and neurite retraction; Lfc and p114-RhoGEF physically bind Dvl and Daam1, and their knockdown suppresses Dvl- and Wnt-3a-induced RhoA activation and neurite retraction.","method":"shRNA screen, Co-IP (Lfc–Dvl, Lfc–Daam1), RhoA activation assay, neurite retraction assay in N1E-115 cells","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — shRNA screen validated by Co-IP and functional RhoA activation/phenotype assays","pmids":["20810787"],"is_preprint":false},{"year":2011,"finding":"Mechanical force on integrins triggers GEF-H1 catalytic activation via ERK downstream of a FAK–Ras signaling cascade, and recruits GEF-H1 to adhesion complexes; this is distinct from LARG activation (which occurs via Fyn), and both GEFs are required for force-induced cellular stiffening (reinforcement).","method":"Magnetic bead force application, biochemical fractionation, GEF activity assay, siRNA knockdown, traction force microscopy","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — biophysical force application combined with biochemical GEF activity assay and siRNA epistasis, multiple orthogonal approaches","pmids":["21572419"],"is_preprint":false},{"year":2011,"finding":"GEF-H1 is required for NOD2- and RIP2-dependent NF-κB activation; GEF-H1 functions downstream of NOD2 as part of RIP2-containing signaling complexes and mediates Src tyrosine kinase-dependent phosphorylation of RIP2; the 3020insC NOD2 variant associated with Crohn's disease fails to activate this GEF-H1-dependent pathway.","method":"siRNA knockdown, Co-IP (GEF-H1–RIP2–NOD2), NF-κB reporter assay, confocal microscopy, macrophage activation assay","journal":"Inflammatory bowel diseases","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP validating complex, siRNA epistasis, disease-variant specificity tested","pmids":["21887730"],"is_preprint":false},{"year":2011,"finding":"PAR1b/MARK2 phosphorylates GEF-H1 at Ser885 and Ser959, inhibiting GEF-H1 RhoA-specific GEF activity and suppressing stress fiber formation; Par1b-phosphorylated GEF-H1 loses the ability to activate RhoA.","method":"In vitro kinase assay, phosphorylation site mutagenesis, RhoA GEF activity assay, stress fiber formation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with specific site mutagenesis and functional GEF activity readout","pmids":["22072711"],"is_preprint":false},{"year":2011,"finding":"Par1b/MARK2 phosphorylates GEF-H1 at multiple conserved serine residues, releasing GEF-H1 from microtubules and abrogating GEF-H1-induced microtubule stabilization/acetylation; non-phosphorylatable GEF-H1 (3SA mutant) remains statically bound to microtubules as visualized by live-cell imaging.","method":"In vitro kinase assay, immunofluorescence, live-cell time-lapse imaging of GFP-GEF-H1, microtubule acetylation assay","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro kinase assay, phosphomutant live imaging, functional microtubule readout","pmids":["21513698"],"is_preprint":false},{"year":2011,"finding":"Calpain-6 (CAPN6) co-localizes and physically interacts with GEF-H1 on microtubules; CAPN6 knockdown causes GEF-H1 to translocate from microtubules to the lamellipodial region and interact with Rac1, leading to Rac1 activation, increased cell migration, and lamellipodial protrusion; this Rac1 activation requires GEF-H1.","method":"siRNA knockdown, Co-IP (CAPN6–GEF-H1), immunofluorescence, Rac1 and RhoA activity assays, migration assay","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP plus siRNA double knockdown epistasis plus Rac/RhoA activity assays","pmids":["21406564"],"is_preprint":false},{"year":2012,"finding":"GEF-H1 directly binds exocyst component Sec5 in a RalA GTPase-dependent manner; this interaction promotes RhoA activation, regulates exocyst assembly/localization, and is required for exocytosis.","method":"Direct binding assay (pulldown), Co-IP (GEF-H1–Sec5, RalA-dependence), RhoA activation assay, exocytosis assay, siRNA knockdown","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct pulldown plus Co-IP, RalA-dependency established, functional exocytosis assay","pmids":["22898781"],"is_preprint":false},{"year":2012,"finding":"Non-centrosomal microtubules anchored by CAMSAP3 (Nezha) preferentially sequester GEF-H1; CAMSAP3 depletion increases the soluble pool of GEF-H1, upregulates RhoA activity, and promotes actin stress fiber formation; detyrosinated microtubules do not efficiently interact with GEF-H1.","method":"siRNA knockdown, RhoA activity assay, immunofluorescence, subcellular fractionation","journal":"Genes to cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA with RhoA activity readout and fractionation, single lab, moderate methods","pmids":["23432781"],"is_preprint":false},{"year":2012,"finding":"GEFH1 binds the BAR domain of ASAP1 (validated by endogenous Co-IP) and colocalizes with ASAP1 in podosomes; GEFH1 overexpression inhibits podosome assembly and ASAP1 GAP activity, while GEFH1 knockdown increases podosome assembly rate.","method":"Yeast two-hybrid, endogenous Co-IP, siRNA knockdown, overexpression, podosome assembly assay","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — endogenous Co-IP plus functional podosome assays, single lab","pmids":["21352810"],"is_preprint":false},{"year":2012,"finding":"Microtubule stability is diminished by a stiff 3D extracellular matrix, leading to activation of GEF-H1 and RhoA; GEF-H1 loss decreases cell contraction and invasion through 3D matrices; MEK/ERK pathway does not contribute to stiffness-induced GEF-H1 activation in this context.","method":"3D matrix stiffness assay, microtubule stability assay, GEF-H1 siRNA, RhoA activity assay, cell contraction/invasion assay","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA with RhoA activity and functional invasion readout, single lab","pmids":["22593214"],"is_preprint":false},{"year":2013,"finding":"GEF-H1 is essential for RIG-I-like receptor sensing of foreign RNA; upon microtubule release GEF-H1 activation controls RIG-I- and Mda5-dependent IRF3 phosphorylation and IFN-β induction; Arhgef2−/− mice show pronounced antiviral signaling defects against encephalomyocarditis virus and influenza A virus.","method":"Arhgef2 knockout mouse generation, viral challenge, IRF3 phosphorylation assay, IFN-β induction assay, siRNA knockdown in macrophages","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout mouse with in vivo viral challenge and biochemical pathway readouts, multiple orthogonal methods","pmids":["24270516"],"is_preprint":false},{"year":2013,"finding":"TNF-α sequentially activates Rac (via GEF-H1 phosphorylation at S885) and then RhoA (via GEF-H1 T678 phosphorylation) through a single exchange factor; GEF-H1-mediated Rac activation drives TACE/ADAM17, which transactivates EGFR/ERK and leads to T678 phosphorylation and RhoA activation.","method":"siRNA knockdown, phospho-specific western blots (T678, S885 mutants), Rac and RhoA activity assays, TACE activity assay","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — phosphosite-specific mutants, siRNA epistasis, sequential activation assays with multiple GTPase readouts","pmids":["23389627"],"is_preprint":false},{"year":2014,"finding":"GEF-H1 acts as an adaptor linking PP2A B' subunits to the scaffold protein KSR-1, mediating dephosphorylation of KSR-1 S392 and activating MAPK signaling downstream of oncogenic RAS; this role is independent of GEF-H1's RhoGEF catalytic activity.","method":"Co-IP (GEF-H1–KSR-1–PP2A), phosphorylation assay, GEF-H1 catalytic mutant analysis, siRNA knockdown, tumor xenograft growth assay","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP establishing ternary complex, catalytic mutant confirming non-GEF mechanism, xenograft functional readout","pmids":["24525234"],"is_preprint":false},{"year":2014,"finding":"MARK3 (activated by LKB1) phosphorylates ARHGEF2 at Ser151, generating a 14-3-3 binding site that disrupts the ARHGEF2–DYNLT1 (Tctex-1) interaction and dissociates ARHGEF2 from microtubules; this stimulates RhoA activation and stress fiber/focal adhesion formation; PP2A dephosphorylates Ser151 to restore the inhibited state.","method":"In vitro kinase assay (MARK3), Co-IP (ARHGEF2–DYNLT1, ARHGEF2–14-3-3), site-directed mutagenesis (S151), 3D culture architecture assay, phosphatase assay","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay with mutagenesis, reciprocal Co-IP, PP2A eraser identified, functional 3D culture phenotype","pmids":["29089450"],"is_preprint":false},{"year":2014,"finding":"RASSF1A stimulates cofilin/PP2A-mediated dephosphorylation of GEF-H1, thereby activating GEF-H1 to activate the antimetastatic GTPase RhoB; RASSF1A loss reduces GEF-H1-mediated RhoB activation and increases nuclear YAP, promoting EMT and invasion.","method":"RNAi silencing, Co-IP, PP2A/cofilin phosphatase assay, RhoB activation assay, in vivo metastasis assay","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and phosphatase assay establishing mechanism, single lab","pmids":["26759237"],"is_preprint":false},{"year":2014,"finding":"GEF-H1 mediates GEF-H1/RhoA activation induced by LPA or thrombin (GPCR ligands) through a mechanism independent of microtubule depolymerization: Gα directly binds GEF-H1 and displaces it from Tctex-1, while Gβγ binds Tctex-1 and disrupts its dynein intermediate chain interaction; full GEF-H1 activation requires subsequent PP2A-mediated dephosphorylation of Ser885.","method":"Co-IP (GEF-H1–Tctex-1–dynein, Gα–GEF-H1, Gβγ–Tctex-1), direct binding assay, GEF-H1 activity assay, phosphatase assay, LPA/thrombin stimulation","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct protein interaction mapping with multiple Co-IPs, in vitro GEF assay, phosphatase identification, multiple orthogonal methods","pmids":["25209408"],"is_preprint":false},{"year":2014,"finding":"GEF-H1 functions in apical constriction and cell intercalation during Xenopus neural tube closure; GEF-H1 depletion (morpholino) causes neural tube defects with impaired MLC phosphorylation, Rab11 and F-actin accumulation; overexpressed GEF-H1 induces ROCK-dependent ectopic apical constriction.","method":"Morpholino knockdown, RNA rescue, lineage tracing, MLC phosphorylation assay, ROCK inhibitor, immunofluorescence in Xenopus embryo","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Strong — morpholino knockdown with mRNA rescue in vivo, ROCK inhibitor epistasis, multiple molecular readouts","pmids":["24681784"],"is_preprint":false},{"year":2015,"finding":"VopO, a Vibrio parahaemolyticus type III effector, directly binds GEF-H1 via an alpha-helix region; this interaction is required for T3SS2-dependent RhoA-ROCK pathway activation and stress fiber formation; GEF-H1 binding activity of VopO correlates with its stress fiber-inducing and epithelial barrier disruption capacity.","method":"Direct pulldown (VopO–GEF-H1), Co-IP, deletion/mutagenesis mapping, RhoA activity assay, transepithelial resistance measurement","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct binding with mutagenesis establishing interaction domain, functional epistasis with GEF-H1 knockdown","pmids":["25738744"],"is_preprint":false},{"year":2015,"finding":"RalB (but not RalA) promotes TGFβ-induced cancer cell dissemination via GEF-H1; RalB acts through the exocyst subunit Sec5 to promote GEF-H1-dependent RhoA activation and actomyosin contractility; uncoupling Sec5 from GEF-H1 impairs RhoA activation and traction force generation.","method":"Co-IP (GEF-H1–Sec5), siRNA knockdown (RalA vs RalB), traction force microscopy, RhoA activation assay, 3D dissemination assay","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP, traction force microscopy, siRNA epistasis with specific GTPase readouts","pmids":["26152517"],"is_preprint":false},{"year":2016,"finding":"The TRPC3 channel mediates mechanical stress/TGFβ-induced GEF-H1 activation in cardiomyocytes and cardiac fibroblasts; TRPC3 functionally interacts with microtubule-associated Nox2, and Nox2 inhibition attenuates mechanical stretch-induced GEF-H1 activation; TRPC3 inhibition suppresses GEF-H1-mediated RhoA activation and fibrotic responses.","method":"Proteomics (TRPC3 interactome), Nox2 inhibitor studies, GEF-H1 activation assay, fibrosis assays in cardiomyocytes/fibroblasts, pressure-overload mouse model","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — proteomics identification plus pharmacological inhibition, single lab","pmids":["27991560"],"is_preprint":false},{"year":2016,"finding":"Autophagy degrades GEF-H1 via a p62-dependent mechanism; in autophagy-deficient cells (Atg5/Atg7/Ulk1 KO), GEF-H1 accumulates, RhoA activity increases, and cells switch to amoeboid migration; GEF-H1 silencing in Atg5 KO cells reverts this phenotype.","method":"Co-IP (GEF-H1–p62), Atg5/Atg7/Ulk1 knockout MEFs, GEF-H1 silencing rescue, RhoA activity assay, cell migration assay","journal":"Oncotarget","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple autophagy-deficient genetic models, Co-IP for p62 interaction, siRNA rescue, RhoA activity assay","pmids":["27120804"],"is_preprint":false},{"year":2016,"finding":"PP2A regulatory subunit PPP2R2A binds, dephosphorylates, and activates GEF-H1 at Ser885, leading to increased RhoA-GTP levels and ROCK activity in T cells, promoting Th1 and Th17 differentiation.","method":"Co-IP (PPP2R2A–GEF-H1), phospho-Ser885 western blot, RhoA activity assay, T cell conditional knockout, Th1/Th17 differentiation assay","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP, phosphatase-specific dephosphorylation readout, conditional KO with specific T cell phenotype","pmids":["33762326"],"is_preprint":false},{"year":2017,"finding":"Vimentin intermediate filaments regulate actin stress fiber assembly via GEF-H1; vimentin loss induces phosphorylation of GEF-H1 at Ser886, promoting RhoA activity and stress fiber assembly; this requires intact vimentin filaments (not unit-length forms).","method":"Vimentin knockout cells, wild-type vs non-filamentous vimentin rescue, Ser886 phosphorylation western blot, RhoA activity assay, MLC phosphorylation assay","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with specific rescue distinguishing filament requirement, phospho-site specific readout, RhoA activity assay","pmids":["28096473"],"is_preprint":false},{"year":2017,"finding":"Homozygous frameshift mutation in ARHGEF2 causes intellectual disability and midbrain-hindbrain malformation; loss of ARHGEF2 perturbs progenitor cell differentiation, shifts mitotic spindle plane orientation toward symmetric divisions, and reduces RhoA/ROCK/MLC pathway activation; Arhgef2 mutant mice recapitulate the human malformation with aberrant precerebellar neuron migration.","method":"Whole exome sequencing, Arhgef2 knockout/mutant mouse, spindle orientation analysis, MLC phosphorylation assay, neuronal migration assay","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — human genetics validated in mouse model with cellular mechanism (spindle orientation, RhoA pathway), multiple readouts","pmids":["28453519"],"is_preprint":false},{"year":2019,"finding":"GEF-H1 contains an autoinhibitory sequence; live-cell biosensor imaging reveals that autoinhibited GEF-H1 localizes to microtubules, while MT depolymerization at the cell cortex activates GEF-H1 in a ~5-µm peripheral band; Src phosphorylation activates GEF-H1 in a narrower ~0-2 µm band at the cell edge in coordination with protrusions.","method":"GEF-H1 activation FRET biosensor, live-cell simultaneous imaging of MT dynamics and GEF-H1 activity, Src inhibitor treatment, autoinhibitory sequence mapping","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — novel biosensor enabling spatiotemporal GEF-H1 activity mapping, autoinhibitory domain identification, pharmacological validation","pmids":["31420453"],"is_preprint":false},{"year":2019,"finding":"GEF-H1 is specifically released upon microtubule destabilization in dendritic cells and drives DC maturation via JNK pathway and AP-1/ATF transcriptional response; GEF-H1 promotes cross-presentation of tumor antigens to CD8 T cells; Arhgef2−/− mice show impaired anti-tumor immunity.","method":"Arhgef2 knockout mice, DC maturation assay, JNK activity assay, antigen cross-presentation assay, in vivo tumor challenge","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with in vivo tumor challenge, JNK/AP-1 pathway dissection, cross-presentation functional assay","pmids":["31553907"],"is_preprint":false},{"year":2019,"finding":"GEF-H1 is required for IKKε-mediated phosphorylation and activation of IRF5 in response to microbial muramyl-dipeptides; GEF-H1 functions in a microtubule-based peptidoglycan recognition system independent of NOD-like receptors; deletion or dominant-negative GEF-H1 prevents IKKε and IRF5 activation and host defenses against Listeria monocytogenes.","method":"GEF-H1 knockout/dominant-negative, IKKε kinase assay, IRF5 phosphorylation assay, Listeria infection model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic tools (KO, dominant-negative), in vitro kinase assay, in vivo infection model with multiple biochemical readouts","pmids":["30902986"],"is_preprint":false},{"year":2020,"finding":"BNIP-2 (a BCH domain protein) binds both GEF-H1 and RhoA and traffics with kinesin-1 on microtubules; upon microtubule disassembly, the BNIP-2–GEF-H1 interaction increases and BNIP-2 scaffolds GEF-H1–RhoA coupling; BNIP-2 depletion reduces RhoA activation and cell rounding after nocodazole treatment.","method":"Co-IP (BNIP-2–GEF-H1, BNIP-2–RhoA), kinesin-1 trafficking assay, siRNA knockdown, RhoA activity assay, live-cell imaging","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP establishing ternary complex, siRNA epistasis, RhoA activity assay, microtubule disassembly context","pmids":["32789168"],"is_preprint":false},{"year":2020,"finding":"PKA and PKG phosphorylate GEF-H1 at Ser886 in platelets, stimulating 14-3-3β binding and promoting GEF-H1 association with microtubules, thereby inhibiting GEF-H1 GEF function; microtubule disruption increases RhoA-GTP levels in platelets, confirming GEF-H1's role in platelet RhoA regulation.","method":"Phosphoproteomics, western blot (Ser886 phosphorylation), Phos-tag gel, 14-3-3 binding pulldown, microtubule disruption assay, RhoA-GTP pulldown","journal":"Journal of thrombosis and haemostasis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phosphoproteomics plus functional pulldown and RhoA activity assay, single lab","pmids":["32692911"],"is_preprint":false},{"year":2021,"finding":"YTHDF1 binds m6A sites on ARHGEF2 mRNA, enhancing ARHGEF2 translation; increased ARHGEF2 protein activates RhoA signaling and promotes CRC tumor growth and metastasis; siRNA-LNP delivery targeting ARHGEF2 suppresses tumor growth in vivo.","method":"m6A-MeRIP-seq, YTHDF1 RIP-seq, proteomics, Ythdf1 knockout mouse (inflammatory CRC model), rescue with ARHGEF2 overexpression, siRNA-LNP in vivo treatment","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiomics defining m6A-YTHDF1-ARHGEF2 axis, genetic KO mouse, in vitro/in vivo rescue, siRNA therapeutic validation","pmids":["34968454"],"is_preprint":false},{"year":2021,"finding":"Glutamine deficiency triggers macropinocytosis in pancreatic cancer-associated fibroblasts via CaMKK2-AMPK signaling and ARHGEF2; ARHGEF2 is required for this stromal macropinocytic response, which supplies amino acids to both CAFs and tumor cells.","method":"siRNA/shRNA knockdown of ARHGEF2, CaMKK2-AMPK inhibition, macropinocytosis assay (imaging), amino acid measurement, xenograft tumor growth assay","journal":"Cancer discovery","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with functional macropinocytosis and tumor growth readout, single lab","pmids":["33653692"],"is_preprint":false},{"year":2021,"finding":"NEK9 directly phosphorylates ARHGEF2, activating RhoA and promoting gastric cancer cell motility; NEK9 is transcriptionally suppressed by miR-520f-3p, which is itself repressed by IL-6/STAT3 signaling, placing ARHGEF2 phosphorylation downstream of the IL-6-STAT3-NEK9 pathway.","method":"In vitro kinase assay (NEK9→ARHGEF2), GST pulldown, Co-IP, phosphoproteomics, miR-520f-3p luciferase reporter, ChIP, RhoA activation assay","journal":"Theranostics","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro kinase assay identifying NEK9 as ARHGEF2 kinase, phosphoproteomics, multiple orthogonal pathway validation methods","pmids":["33500736"],"is_preprint":false},{"year":2021,"finding":"Bartonella effector BepC binds GEF-H1 via its N-terminal FIC domain (in a non-catalytic manner) and re-localizes GEF-H1 from microtubules to the plasma membrane; this GEF-H1-dependent mechanism activates RhoA/ROCK and triggers actin stress fiber formation and cell fragmentation in migrating endothelial cells.","method":"Interactomic analysis (Co-IP/MS), GEF-H1 knockout cell lines, BepC domain mapping/mutagenesis, ROCK inhibitor, immunofluorescence","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 / Strong — interactomics plus genetic KO cells, BepC domain mutagenesis, pharmacological pathway confirmation","pmids":["33508040"],"is_preprint":false},{"year":2022,"finding":"Peptide inhibitors designed against the GEF-H1 autoregulatory C-terminal domain block RhoA/GEF-H1 binding in vitro and inhibit GEF-H1-dependent TGFβ-induced fibrosis, LPS-stimulated endothelial barrier disruption, and cell migration; the most potent inhibitor inhibits blood vessel leakage and retinal inflammation in an in vivo retinal disease model.","method":"In silico peptide design, in vitro RhoA/GEF-H1 binding assay, cell-based permeability and migration assays, in vivo retinal disease mouse model","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — in vitro biochemical blocking assay, in vivo validation, but peptide tool compounds with modest mechanistic novelty","pmids":["35681428"],"is_preprint":false},{"year":2023,"finding":"HUNK kinase directly phosphorylates GEF-H1 at Ser645, which activates RhoA and leads to cascading phosphorylation of LIMK-1/CFL-1, stabilizing F-actin and inhibiting EMT in colorectal cancer.","method":"In vitro kinase assay (HUNK→GEF-H1 S645), phospho-specific western blot, RhoA/LIMK-1/CFL-1 activity assays, siRNA/overexpression in CRC cells, in vivo metastasis model","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay identifying specific phosphorylation site, downstream pathway cascade validated, in vivo functional readout","pmids":["37193711"],"is_preprint":false},{"year":2012,"finding":"FAM123A binds to ARHGEF2 via a microtubule-associated interaction, and this binding inhibits ARHGEF2 GEF activity; FAM123A depletion increases actomyosin contractility, focal adhesion size, and decreases cell migration in an ARHGEF2-dependent manner.","method":"Affinity purification/mass spectrometry, domain interaction assay, siRNA knockdown, actomyosin contractility assay, focal adhesion size measurement, cell migration assay","journal":"Science signaling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — MS-defined interaction with siRNA epistasis and functional readout, single lab","pmids":["22949735"],"is_preprint":false},{"year":2011,"finding":"hPTTG1 transcriptionally activates GEF-H1 gene expression by directly binding and activating the GEF-H1 promoter (validated by luciferase reporter and ChIP); hPTTG1 knockdown decreases GEF-H1 expression and RhoA activation, reducing breast cancer cell motility and invasion, rescued by GEF-H1 re-expression.","method":"Luciferase reporter assay, ChIP assay, siRNA knockdown, RhoA activity assay, invasion/migration assay, in vivo metastasis model","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP plus luciferase reporter establishing direct transcriptional regulation, siRNA with in vivo rescue","pmids":["22002306"],"is_preprint":false},{"year":2016,"finding":"Tension on JAM-A activates RhoA via GEF-H1 (and p115 RhoGEF) through PI3K-mediated GEF-H1 activation; FAK/ERK further regulate GEF-H1; phosphorylation of JAM-A at Ser284 is required for this RhoA activation in response to tension.","method":"Magnetic bead tension application, PI3K inhibitor, siRNA knockdown of GEF-H1 and p115, RhoA activity assay, JAM-A phospho-mutant analysis","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — force application with siRNA epistasis and RhoA activity readout, single lab","pmids":["26985018"],"is_preprint":false},{"year":2016,"finding":"ONCOGENIC KRAS transcriptionally activates ARHGEF2 through a minimal RAS-responsive promoter regulated by ELK1, ETS1, SP1, SP3 (positive) and RREB1 (negative); RREB1 knockdown increases ARHGEF2 expression and extends RhoA activation duration; ARHGEF2 rescues SP3 loss-of-function invasion/migration defects.","method":"Promoter reporter assay, transcription factor ChIP/knockdown, ARHGEF2 overexpression rescue, RhoA activation assay, invasion/migration assay","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter reporter and siRNA epistasis with functional readouts, single lab","pmids":["27835861"],"is_preprint":false}],"current_model":"ARHGEF2/GEF-H1 is a RhoA (and to a lesser extent Rac1) guanine nucleotide exchange factor that is held in an inactive, autoinhibited state when bound to polymerized microtubules via its coiled-coil domain; microtubule depolymerization, or displacement by binding partners (Gα subunits, Bartonella BepC, RalA–Sec5), releases GEF-H1 and allows RhoA activation that drives actin stress fiber formation, cell contractility, cytokinesis, barrier regulation, and innate immune signaling. GEF-H1 activity is further tuned by a network of phosphorylation events: PAK1, PAK4, ERK1/2, Aurora A/B, Cdk1, MARK2/PAR1b, MARK3 (LKB1-activated), NEK9, PKA/PKG, and HUNK each phosphorylate distinct GEF-H1 residues (notably Ser885/886, Thr678, Ser151, Ser645, Ser810, Ser959) to either inhibit (by creating 14-3-3 binding sites that tether GEF-H1 to microtubules) or activate (by enhancing exchange activity) the protein, while PP2A dephosphorylates Ser885 and Ser151 to restore activity; GEF-H1 also acts as a non-catalytic adaptor linking PP2A to KSR-1 for MAPK activation, interacts with NOD1/NOD2–RIP2 complexes for NF-κB and IRF5 innate immune signaling, and is sequestered at tight junctions by cingulin and paracingulin to control epithelial RhoA activity and proliferation."},"narrative":{"mechanistic_narrative":"ARHGEF2 (GEF-H1/Lfc) is a Dbl-family guanine nucleotide exchange factor that catalytically and specifically activates RhoA (and to a lesser extent Rac1) to drive actin stress fiber formation, cell contractility, mitotic spindle assembly, epithelial barrier regulation, and innate immune signaling [PMID:8910315, PMID:9857026, PMID:9890991]. Its activity is gated by microtubule binding through its C-terminal coiled-coil region: microtubule-associated GEF-H1 is held in an autoinhibited state, and microtubule depolymerization or release from the cytoskeleton liberates active GEF-H1 to load GTP onto RhoA [PMID:11912491, PMID:18287519, PMID:31420453]. Release is achieved by diverse inputs — drug-induced or mechanically/matrix-stiffness-induced microtubule destabilization [PMID:18287519, PMID:22593214], displacement by Gα subunits and RalA–Sec5 exocyst coupling downstream of GPCR ligands [PMID:25209408, PMID:22898781], and bacterial effectors (EPEC EspG/Orf3, Vibrio VopO, Bartonella BepC) that destabilize microtubules or directly bind and relocalize GEF-H1 to activate RhoA-ROCK signaling [PMID:15318166, PMID:25738744, PMID:33508040]. A dense phosphoregulatory network tunes the protein: phosphorylation by PAK1, PAK4, PAR1b/MARK2, MARK3, PKA/PKG creates 14-3-3 binding sites that tether GEF-H1 to microtubules and suppress exchange activity, while ERK (Thr678), NEK9, and HUNK (Ser645) phosphorylation enhance activity; PP2A reverses inhibitory phosphorylation at Ser885/Ser151 to restore activity [PMID:14970201, PMID:15827085, PMID:22072711, PMID:29089450, PMID:18211802, PMID:33500736, PMID:37193711, PMID:33762326, PMID:25209408]. GEF-H1 is sequestered at tight junctions by cingulin and paracingulin to restrain epithelial RhoA and G1/S progression [PMID:15866167, PMID:18653465], and is essential for RhoA-dependent mitotic spindle assembly and cleavage-furrow Rho activation during cytokinesis [PMID:15976019, PMID:17488622]. Beyond its catalytic role, GEF-H1 acts as a non-catalytic adaptor linking PP2A to the scaffold KSR-1 to activate MAPK downstream of oncogenic RAS [PMID:24525234], and is required for innate immune signaling through NOD1/NOD2–RIP2 to NF-κB, RIG-I/Mda5 to IRF3/IFN-β, and an IKKε–IRF5 peptidoglycan-sensing pathway [PMID:19043560, PMID:21887730, PMID:24270516, PMID:30902986]. Homozygous frameshift mutation in ARHGEF2 causes intellectual disability and midbrain-hindbrain malformation, with loss shifting mitotic spindle orientation toward symmetric divisions and reducing RhoA/ROCK/MLC signaling [PMID:28453519].","teleology":[{"year":1996,"claim":"Established that ARHGEF2 is a catalytically active, substrate-selective exchange factor, defining its core biochemical identity.","evidence":"In vitro GDP dissociation and GTPγS exchange assays with RhoA, Rac, Cdc42, and Ras","pmids":["8910315","9857026"],"confidence":"High","gaps":["Cellular triggers of exchange activity not yet defined","Relative physiological weight of RhoA vs Rac activity unresolved"]},{"year":1999,"claim":"Linked GEF activity to a cytoskeletal localization, showing GEF-H1 acts on RhoA/Rac to remodel actin and signal to JNK.","evidence":"Immunofluorescence localization, dominant-negative GTPase epistasis, and JNK assays in NIH 3T3 cells","pmids":["9890991","7629163"],"confidence":"High","gaps":["Mechanism coupling microtubule localization to activity state not established","Domain basis of autoinhibition unknown"]},{"year":2002,"claim":"Defined the central regulatory logic: microtubule-bound GEF-H1 is inactive and microtubule depolymerization activates RhoA, resolving how cytoskeletal state controls exchange activity.","evidence":"Microtubule-binding mutants, nocodazole treatment, and dominant-negative epistasis with morphology readouts","pmids":["11912491"],"confidence":"High","gaps":["Molecular nature of the autoinhibited conformation not defined","How depolymerization is sensed and transmitted unclear"]},{"year":2005,"claim":"Revealed phosphorylation-coupled 14-3-3 binding as the molecular switch tethering GEF-H1 to microtubules, and PAK4 as a writer producing alternative (lamellipodial) outputs.","evidence":"In vitro kinase assays (PAK1 Ser885, PAK4 Ser810), site mutagenesis, and 14-3-3 Co-IP","pmids":["14970201","15827085"],"confidence":"High","gaps":["Erasers restoring active state not yet identified","Stoichiometry and combinatorial logic of multisite phosphorylation unknown"]},{"year":2005,"claim":"Demonstrated regulated sequestration by binding partners (cingulin, neurabin/spinophilin) couples GEF-H1-RhoA to tight-junction and synaptic morphology, extending its role beyond microtubules.","evidence":"Direct binding, Co-IP, RNAi, and morphology/cell cycle readouts in MDCK cells and neurons","pmids":["15866167","15996550"],"confidence":"High","gaps":["Whether junction and microtubule pools are exchangeable not resolved","Quantitative contribution of each sequestering partner unclear"]},{"year":2007,"claim":"Placed GEF-H1 in cell-cycle control, showing mitotic kinases inhibit it and timed dephosphorylation enables furrow RhoA activation distinct from Ect2.","evidence":"In vitro Aurora A/B and Cdk1/CyclinB kinase assays, FRET RhoA biosensor, and siRNA in mitotic cells","pmids":["17488622","15976019"],"confidence":"High","gaps":["Phosphatase timing the mitotic-exit activation not pinned down","Spatial coordination with Ect2 not fully mapped"]},{"year":2008,"claim":"Established GEF-H1 as the necessary and sufficient transducer of microtubule depolymerization into RhoA-ROCK-MLC contractility, and identified ERK (Thr678) as an activating writer.","evidence":"siRNA with rescue, RhoA/ROCK/MLC readouts, and in vitro ERK phosphorylation with mutagenesis","pmids":["18287519","18211802"],"confidence":"High","gaps":["How activating versus inhibitory phosphorylation are integrated unclear","Upstream signals selecting ERK input not defined"]},{"year":2009,"claim":"Expanded GEF-H1 into innate immunity, GPCR-linked transcription, and inhibitory adaptors, showing it transduces pathogen and receptor signals to RhoA/RhoB and gene expression.","evidence":"NOD1 Co-IP/NF-κB reporter, TRIF-dependent RhoB activation in DCs, ZONAB/cyclin D1 reporter, Tctex-1/AKAP121-PKA, paracingulin binding","pmids":["19043560","16917499","19730435","19667072","20463241","18653465","19208802"],"confidence":"High","gaps":["GTPase selectivity (RhoA vs RhoB vs Rac) per stimulus not mechanistically explained","How the same GEF reaches distinct downstream programs unresolved"]},{"year":2011,"claim":"Showed mechanical force and additional kinases/partners (PAR1b/MARK2, CAPN6) reroute GEF-H1 output between RhoA and Rac, linking it to mechanotransduction and adhesion reinforcement.","evidence":"Magnetic bead force with GEF assays, in vitro MARK2 kinase assays, and CAPN6 Co-IP/siRNA with Rac1 activation","pmids":["21572419","22072711","21513698","21406564","21887730","22002306"],"confidence":"High","gaps":["Determinants of RhoA-versus-Rac choice at adhesions unclear","Integration of force and phosphorylation inputs not quantitatively modeled"]},{"year":2012,"claim":"Identified non-microtubule scaffolds (Sec5/RalA exocyst, ASAP1, FAM123A, CAMSAP3) that localize and gate GEF-H1, broadening its role into exocytosis and non-centrosomal microtubule control.","evidence":"Direct binding/Co-IP, RalA-dependency tests, siRNA with RhoA/Rac activity and exocytosis/podosome readouts","pmids":["22898781","21352810","22949735","23432781"],"confidence":"Medium","gaps":["Several interactions rest on single-lab Co-IP/MS without reciprocal in vivo validation","Hierarchy among competing sequestering partners unknown"]},{"year":2013,"claim":"Defined GEF-H1 as a master antiviral sensor and showed a single GEF can sequentially activate Rac then RhoA via distinct phosphosites in cytokine signaling.","evidence":"Arhgef2 knockout mice with viral challenge and IRF3/IFN-β readouts; phosphosite-mutant Rac/RhoA activation assays for TNF-α","pmids":["24270516","23389627"],"confidence":"High","gaps":["Molecular basis distinguishing Rac- versus RhoA-directed conformations unresolved","How microtubule release links to RNA sensing mechanistically unclear"]},{"year":2014,"claim":"Uncovered a catalysis-independent adaptor function (PP2A–KSR-1–MAPK) and defined a MARK3/LKB1–PP2A writer-eraser pair at Ser151, plus GPCR-driven activation via Gα/Gβγ displacement of Tctex-1.","evidence":"Co-IP of ternary complexes, GEF-catalytic-dead mutants, in vitro MARK3 kinase assay, and direct G-protein binding with phosphatase assays","pmids":["24525234","29089450","25209408","26759237","24681784"],"confidence":"High","gaps":["Structural basis of the adaptor versus catalytic modes not resolved","How PP2A is targeted to specific GEF-H1 sites unclear"]},{"year":2016,"claim":"Showed protein turnover (autophagy/p62) and stiffness/channel signaling (TRPC3-Nox2) regulate GEF-H1 abundance and activity, controlling migration mode and fibrotic responses.","evidence":"Autophagy-deficient knockouts with p62 Co-IP, TRPC3 interactomics/inhibition, and JAM-A tension experiments","pmids":["27120804","27991560","26985018","33762326"],"confidence":"High","gaps":["Signals selecting degradation versus phosphoregulation unknown","TRPC3-Nox2 mechanism rests on single-lab pharmacology"]},{"year":2019,"claim":"Provided spatiotemporal resolution of activation and extended innate roles, mapping autoinhibited microtubule pool versus cortically activated pools and IKKε–IRF5 and DC cross-presentation functions.","evidence":"GEF-H1 FRET biosensor with live MT imaging, Src inhibition, and Arhgef2 knockout immune/infection models","pmids":["31420453","30902986","31553907"],"confidence":"High","gaps":["Structural autoinhibition mechanism still not solved at atomic level","How peripheral activation bands are spatially restricted unclear"]},{"year":2021,"claim":"Connected disease-relevant transcriptional, translational, and kinase inputs (NEK9, HUNK, KRAS promoter control, m6A/YTHDF1) to GEF-H1-RhoA in cancer and metabolic stress.","evidence":"In vitro kinase assays (NEK9, HUNK Ser645), m6A-MeRIP/RIP-seq with knockout mouse, KRAS promoter dissection, and macropinocytosis assays","pmids":["33500736","37193711","34968454","27835861","33653692","26152517","32789168","32692911","33508040","25738744"],"confidence":"High","gaps":["Integration of transcriptional, translational, and post-translational control into one quantitative model lacking","Tissue-specific dominance of each regulatory axis unresolved"]},{"year":2022,"claim":"Validated GEF-H1's autoregulatory C-terminus as a druggable target, blocking RhoA binding to suppress fibrosis, barrier disruption, and vascular leakage in vivo.","evidence":"In silico-designed peptide inhibitors with in vitro binding and in vivo retinal disease model","pmids":["35681428"],"confidence":"Medium","gaps":["Tool-compound specificity and pharmacokinetics not fully characterized","Selectivity over other RhoGEFs not established"]},{"year":null,"claim":"A unified structural and quantitative model explaining how a single GEF integrates microtubule state, dozens of phosphorylation events, competing sequestering partners, and adaptor functions to select between RhoA, Rac, RhoB, and non-catalytic outputs remains to be built.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No atomic structure of full-length autoinhibited or activated GEF-H1","Rules governing GTPase-output selection per stimulus undefined","Hierarchy and crosstalk among regulatory inputs unresolved"]}],"mechanism_profile":{"molecular_activity":[],"localization":[{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[2,4,49]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[7,32]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[13,10]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,57]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[17]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,14,40]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[16,27,35,51]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[10,13,48]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[48,54,37]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[31,43]}],"complexes":["NOD2-RIP2 signaling complex","exocyst (via Sec5)","PP2A-KSR-1 adaptor complex","AMPA receptor complex"],"partners":["RHOA","RAC1","TCTEX-1/DYNLT1","14-3-3","CINGULIN","SEC5","NOD1","RIP2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q92974","full_name":"Rho guanine nucleotide exchange factor 2","aliases":["Guanine nucleotide exchange factor H1","GEF-H1","Microtubule-regulated Rho-GEF","Proliferating cell nucleolar antigen p40"],"length_aa":986,"mass_kda":111.5,"function":"Activates Rho-GTPases by promoting the exchange of GDP for GTP. May be involved in epithelial barrier permeability, cell motility and polarization, dendritic spine morphology, antigen presentation, leukemic cell differentiation, cell cycle regulation, innate immune response, and cancer. Binds Rac-GTPases, but does not seem to promote nucleotide exchange activity toward Rac-GTPases, which was uniquely reported in PubMed:9857026. May stimulate instead the cortical activity of Rac. Inactive toward CDC42, TC10, or Ras-GTPases. Forms an intracellular sensing system along with NOD1 for the detection of microbial effectors during cell invasion by pathogens. Required for RHOA and RIP2 dependent NF-kappaB signaling pathways activation upon S.flexneri cell invasion. Involved not only in sensing peptidoglycan (PGN)-derived muropeptides through NOD1 that is independent of its GEF activity, but also in the activation of NF-kappaB by Shigella effector proteins (IpgB2 and OspB) which requires its GEF activity and the activation of RhoA. Involved in innate immune signaling transduction pathway promoting cytokine IL6/interleukin-6 and TNF secretion in macrophage upon stimulation by bacterial peptidoglycans; acts as a signaling intermediate between NOD2 receptor and RIPK2 kinase. Contributes to the tyrosine phosphorylation of RIPK2 through Src tyrosine kinase leading to NF-kappaB activation by NOD2. Overexpression activates Rho-, but not Rac-GTPases, and increases paracellular permeability (By similarity). Involved in neuronal progenitor cell division and differentiation (PubMed:28453519). Involved in the migration of precerebellar neurons (By similarity)","subcellular_location":"Cytoplasm, cytoskeleton; Cytoplasm; Cell junction, tight junction; Golgi apparatus; Cytoplasm, cytoskeleton, spindle; Cell projection, ruffle membrane; Cytoplasmic vesicle","url":"https://www.uniprot.org/uniprotkb/Q92974/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ARHGEF2","classification":"Not Classified","n_dependent_lines":22,"n_total_lines":1208,"dependency_fraction":0.018211920529801324},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"ANKRD28","stoichiometry":10.0},{"gene":"PPP2CA","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/ARHGEF2","total_profiled":1310},"omim":[{"mim_id":"617523","title":"NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM","url":"https://www.omim.org/entry/617523"},{"mim_id":"609473","title":"CINGULIN; CGN","url":"https://www.omim.org/entry/609473"},{"mim_id":"607560","title":"RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; ARHGEF2","url":"https://www.omim.org/entry/607560"},{"mim_id":"605451","title":"p21 PROTEIN-ACTIVATED KINASE 4; PAK4","url":"https://www.omim.org/entry/605451"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ARHGEF2"},"hgnc":{"alias_symbol":["LFP40","GEF-H1","KIAA0651","P40","Lfc","GEFH1"],"prev_symbol":[]},"alphafold":{"accession":"Q92974","domains":[{"cath_id":"3.30.60.20","chopping":"34-93","consensus_level":"medium","plddt":82.8583,"start":34,"end":93},{"cath_id":"1.20.900.10","chopping":"194-436","consensus_level":"high","plddt":92.6254,"start":194,"end":436},{"cath_id":"2.30.29.30","chopping":"453-574","consensus_level":"high","plddt":92.0217,"start":453,"end":574},{"cath_id":"1.20.5","chopping":"2-30","consensus_level":"medium","plddt":60.9197,"start":2,"end":30}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92974","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q92974-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q92974-F1-predicted_aligned_error_v6.png","plddt_mean":69.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ARHGEF2","jax_strain_url":"https://www.jax.org/strain/search?query=ARHGEF2"},"sequence":{"accession":"Q92974","fasta_url":"https://rest.uniprot.org/uniprotkb/Q92974.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q92974/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92974"}},"corpus_meta":[{"pmid":"11912491","id":"PMC_11912491","title":"Nucleotide exchange factor GEF-H1 mediates cross-talk between microtubules and the actin cytoskeleton.","date":"2002","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11912491","citation_count":548,"is_preprint":false},{"pmid":"21572419","id":"PMC_21572419","title":"The Rho GEFs LARG and GEF-H1 regulate the mechanical response to force on integrins.","date":"2011","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21572419","citation_count":305,"is_preprint":false},{"pmid":"18287519","id":"PMC_18287519","title":"GEF-H1 couples nocodazole-induced microtubule disassembly to cell contractility via RhoA.","date":"2008","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/18287519","citation_count":284,"is_preprint":false},{"pmid":"9857026","id":"PMC_9857026","title":"Cloning and characterization of GEF-H1, a microtubule-associated guanine nucleotide exchange factor for Rac and Rho GTPases.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9857026","citation_count":262,"is_preprint":false},{"pmid":"17488622","id":"PMC_17488622","title":"GEF-H1 modulates localized RhoA activation during cytokinesis under the control of mitotic kinases.","date":"2007","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/17488622","citation_count":190,"is_preprint":false},{"pmid":"15866167","id":"PMC_15866167","title":"Binding of GEF-H1 to the tight junction-associated adaptor cingulin results in inhibition of Rho signaling and G1/S phase transition.","date":"2005","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/15866167","citation_count":177,"is_preprint":false},{"pmid":"32724467","id":"PMC_32724467","title":"Hypoxia induced exosomal circRNA promotes metastasis of Colorectal Cancer via targeting GEF-H1/RhoA axis.","date":"2020","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/32724467","citation_count":172,"is_preprint":false},{"pmid":"7629163","id":"PMC_7629163","title":"Expression cloning of lfc, a novel oncogene with structural similarities to guanine nucleotide exchange factors and to the regulatory region of protein kinase C.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7629163","citation_count":167,"is_preprint":false},{"pmid":"34968454","id":"PMC_34968454","title":"N6-Methyladenosine Reader YTHDF1 Promotes ARHGEF2 Translation and RhoA Signaling in Colorectal Cancer.","date":"2021","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/34968454","citation_count":159,"is_preprint":false},{"pmid":"18394899","id":"PMC_18394899","title":"Cellular functions of GEF-H1, a microtubule-regulated Rho-GEF: is altered GEF-H1 activity a crucial determinant of disease pathogenesis?","date":"2008","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18394899","citation_count":157,"is_preprint":false},{"pmid":"14970201","id":"PMC_14970201","title":"p21-activated kinase 1 phosphorylates and regulates 14-3-3 binding to GEF-H1, a microtubule-localized Rho exchange factor.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14970201","citation_count":156,"is_preprint":false},{"pmid":"28096473","id":"PMC_28096473","title":"Vimentin intermediate filaments control actin stress fiber assembly through GEF-H1 and RhoA.","date":"2017","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/28096473","citation_count":150,"is_preprint":false},{"pmid":"16257999","id":"PMC_16257999","title":"GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction.","date":"2005","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16257999","citation_count":144,"is_preprint":false},{"pmid":"15827085","id":"PMC_15827085","title":"PAK4 mediates morphological changes through the regulation of GEF-H1.","date":"2005","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/15827085","citation_count":143,"is_preprint":false},{"pmid":"9890991","id":"PMC_9890991","title":"The Dbl-related protein, Lfc, localizes to microtubules and mediates the activation of Rac signaling pathways in cells.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9890991","citation_count":140,"is_preprint":false},{"pmid":"15318166","id":"PMC_15318166","title":"Enteropathogenic Escherichia coli activates the RhoA signaling pathway via the stimulation of GEF-H1.","date":"2004","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/15318166","citation_count":129,"is_preprint":false},{"pmid":"8910315","id":"PMC_8910315","title":"Lfc and Lsc oncoproteins represent two new guanine nucleotide exchange factors for the Rho GTP-binding protein.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8910315","citation_count":125,"is_preprint":false},{"pmid":"15996550","id":"PMC_15996550","title":"The Rho-specific GEF Lfc interacts with neurabin and spinophilin to regulate dendritic spine morphology.","date":"2005","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/15996550","citation_count":121,"is_preprint":false},{"pmid":"26759237","id":"PMC_26759237","title":"RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non-Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway.","date":"2016","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/26759237","citation_count":100,"is_preprint":false},{"pmid":"19043560","id":"PMC_19043560","title":"GEF-H1 mediated control of NOD1 dependent NF-kappaB activation by Shigella effectors.","date":"2008","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/19043560","citation_count":99,"is_preprint":false},{"pmid":"33653692","id":"PMC_33653692","title":"Macropinocytosis in Cancer-Associated Fibroblasts Is Dependent on CaMKK2/ARHGEF2 Signaling and Functions to Support Tumor and Stromal Cell Fitness.","date":"2021","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/33653692","citation_count":96,"is_preprint":false},{"pmid":"20348280","id":"PMC_20348280","title":"Mechanotransduction by GEF-H1 as a novel mechanism of ventilator-induced vascular endothelial permeability.","date":"2010","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20348280","citation_count":94,"is_preprint":false},{"pmid":"16778209","id":"PMC_16778209","title":"Mutant p53 induces the GEF-H1 oncogene, a guanine nucleotide exchange factor-H1 for RhoA, resulting in accelerated cell proliferation in tumor cells.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16778209","citation_count":92,"is_preprint":false},{"pmid":"19261619","id":"PMC_19261619","title":"GEF-H1 mediates tumor necrosis factor-alpha-induced Rho activation and myosin phosphorylation: role in the regulation of tubular paracellular permeability.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19261619","citation_count":86,"is_preprint":false},{"pmid":"24525234","id":"PMC_24525234","title":"The RhoGEF GEF-H1 is required for oncogenic RAS signaling via KSR-1.","date":"2014","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/24525234","citation_count":85,"is_preprint":false},{"pmid":"18653465","id":"PMC_18653465","title":"Paracingulin regulates the activity of Rac1 and RhoA GTPases by recruiting Tiam1 and GEF-H1 to epithelial junctions.","date":"2008","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/18653465","citation_count":82,"is_preprint":false},{"pmid":"20089843","id":"PMC_20089843","title":"The RhoA activator GEF-H1/Lfc is a transforming growth factor-beta target gene and effector that regulates alpha-smooth muscle actin expression and cell migration.","date":"2010","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/20089843","citation_count":81,"is_preprint":false},{"pmid":"22593214","id":"PMC_22593214","title":"Microtubules regulate GEF-H1 in response to extracellular matrix stiffness.","date":"2012","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/22593214","citation_count":81,"is_preprint":false},{"pmid":"19448628","id":"PMC_19448628","title":"Lfc and Tctex-1 regulate the genesis of neurons from cortical precursor cells.","date":"2009","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19448628","citation_count":75,"is_preprint":false},{"pmid":"18211802","id":"PMC_18211802","title":"ERK1/2 phosphorylate GEF-H1 to enhance its guanine nucleotide exchange activity toward RhoA.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18211802","citation_count":74,"is_preprint":false},{"pmid":"27991560","id":"PMC_27991560","title":"TRPC3-GEF-H1 axis mediates pressure overload-induced cardiac fibrosis.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27991560","citation_count":71,"is_preprint":false},{"pmid":"19208802","id":"PMC_19208802","title":"AMPA receptor and GEF-H1/Lfc complex regulates dendritic spine development through RhoA signaling cascade.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19208802","citation_count":65,"is_preprint":false},{"pmid":"19667072","id":"PMC_19667072","title":"Modulation of Rho guanine exchange factor Lfc activity by protein kinase A-mediated phosphorylation.","date":"2009","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19667072","citation_count":63,"is_preprint":false},{"pmid":"22002306","id":"PMC_22002306","title":"Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling.","date":"2011","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/22002306","citation_count":60,"is_preprint":false},{"pmid":"21212278","id":"PMC_21212278","title":"The epidermal growth factor receptor mediates tumor necrosis factor-alpha-induced activation of the ERK/GEF-H1/RhoA pathway in tubular epithelium.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21212278","citation_count":60,"is_preprint":false},{"pmid":"25209408","id":"PMC_25209408","title":"Mechanistic insight into GPCR-mediated activation of the microtubule-associated RhoA exchange factor GEF-H1.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25209408","citation_count":59,"is_preprint":false},{"pmid":"31553907","id":"PMC_31553907","title":"GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-tumor Responses.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31553907","citation_count":57,"is_preprint":false},{"pmid":"15976019","id":"PMC_15976019","title":"The Rho GTP exchange factor Lfc promotes spindle assembly in early mitosis.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15976019","citation_count":56,"is_preprint":false},{"pmid":"22898781","id":"PMC_22898781","title":"The microtubule-associated Rho activating factor GEF-H1 interacts with exocyst complex to regulate vesicle traffic.","date":"2012","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/22898781","citation_count":55,"is_preprint":false},{"pmid":"16917499","id":"PMC_16917499","title":"TRIF-GEFH1-RhoB pathway is involved in MHCII expression on dendritic cells that is critical for CD4 T-cell activation.","date":"2006","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/16917499","citation_count":53,"is_preprint":false},{"pmid":"22072711","id":"PMC_22072711","title":"Polarity-regulating kinase partitioning-defective 1b (PAR1b) phosphorylates guanine nucleotide exchange factor H1 (GEF-H1) to regulate RhoA-dependent actin cytoskeletal reorganization.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22072711","citation_count":53,"is_preprint":false},{"pmid":"31420453","id":"PMC_31420453","title":"Spatiotemporal dynamics of GEF-H1 activation controlled by microtubule- and Src-mediated pathways.","date":"2019","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31420453","citation_count":52,"is_preprint":false},{"pmid":"19730435","id":"PMC_19730435","title":"The Y-box factor ZONAB/DbpA associates with GEF-H1/Lfc and mediates Rho-stimulated transcription.","date":"2009","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/19730435","citation_count":46,"is_preprint":false},{"pmid":"33126816","id":"PMC_33126816","title":"Regulation and functions of the RhoA regulatory guanine nucleotide exchange factor GEF-H1.","date":"2020","source":"Small GTPases","url":"https://pubmed.ncbi.nlm.nih.gov/33126816","citation_count":46,"is_preprint":false},{"pmid":"29089450","id":"PMC_29089450","title":"MARK3-mediated phosphorylation of ARHGEF2 couples microtubules to the actin cytoskeleton to establish cell polarity.","date":"2017","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/29089450","citation_count":46,"is_preprint":false},{"pmid":"22226472","id":"PMC_22226472","title":"GEF-H1-RhoA signaling pathway mediates LPS-induced NF-κB transactivation and IL-8 synthesis in endothelial cells.","date":"2012","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22226472","citation_count":45,"is_preprint":false},{"pmid":"25143398","id":"PMC_25143398","title":"TGF-β regulates LARG and GEF-H1 during EMT to affect stiffening response to force and cell invasion.","date":"2014","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/25143398","citation_count":45,"is_preprint":false},{"pmid":"20237148","id":"PMC_20237148","title":"Extracellular signal-regulated kinase and GEF-H1 mediate depolarization-induced Rho activation and paracellular permeability increase.","date":"2010","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20237148","citation_count":44,"is_preprint":false},{"pmid":"24270516","id":"PMC_24270516","title":"GEF-H1 controls microtubule-dependent sensing of nucleic acids for antiviral host defenses.","date":"2013","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24270516","citation_count":44,"is_preprint":false},{"pmid":"24681784","id":"PMC_24681784","title":"GEF-H1 functions in apical constriction and cell intercalations and is essential for vertebrate neural tube closure.","date":"2014","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/24681784","citation_count":41,"is_preprint":false},{"pmid":"22847784","id":"PMC_22847784","title":"GEF-H1 over-expression in hepatocellular carcinoma promotes cell motility via activation of RhoA signalling.","date":"2012","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22847784","citation_count":39,"is_preprint":false},{"pmid":"21406564","id":"PMC_21406564","title":"Calpain-6, a microtubule-stabilizing protein, regulates Rac1 activity and cell motility through interaction with GEF-H1.","date":"2011","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/21406564","citation_count":39,"is_preprint":false},{"pmid":"23057787","id":"PMC_23057787","title":"Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells.","date":"2012","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23057787","citation_count":39,"is_preprint":false},{"pmid":"20810787","id":"PMC_20810787","title":"Involvement of p114-RhoGEF and Lfc in Wnt-3a- and dishevelled-induced RhoA activation and neurite retraction in N1E-115 mouse neuroblastoma cells.","date":"2010","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/20810787","citation_count":38,"is_preprint":false},{"pmid":"33500736","id":"PMC_33500736","title":"NEK9, a novel effector of IL-6/STAT3, regulates metastasis of gastric cancer by targeting ARHGEF2 phosphorylation.","date":"2021","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/33500736","citation_count":37,"is_preprint":false},{"pmid":"22513363","id":"PMC_22513363","title":"Heparanase-induced GEF-H1 signaling regulates the cytoskeletal dynamics of brain metastatic breast cancer cells.","date":"2012","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/22513363","citation_count":37,"is_preprint":false},{"pmid":"24739883","id":"PMC_24739883","title":"Stiffness-activated GEF-H1 expression exacerbates LPS-induced lung inflammation.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24739883","citation_count":36,"is_preprint":false},{"pmid":"21887730","id":"PMC_21887730","title":"Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1.","date":"2011","source":"Inflammatory bowel diseases","url":"https://pubmed.ncbi.nlm.nih.gov/21887730","citation_count":36,"is_preprint":false},{"pmid":"26985018","id":"PMC_26985018","title":"Tension on JAM-A activates RhoA via GEF-H1 and p115 RhoGEF.","date":"2016","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/26985018","citation_count":35,"is_preprint":false},{"pmid":"21513698","id":"PMC_21513698","title":"Dynamic regulation of GEF-H1 localization at microtubules by Par1b/MARK2.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/21513698","citation_count":35,"is_preprint":false},{"pmid":"23389627","id":"PMC_23389627","title":"Central role of the exchange factor GEF-H1 in TNF-α-induced sequential activation of Rac, ADAM17/TACE, and RhoA in tubular epithelial cells.","date":"2013","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/23389627","citation_count":35,"is_preprint":false},{"pmid":"24706358","id":"PMC_24706358","title":"Paxillin mediates stretch-induced Rho signaling and endothelial permeability via assembly of paxillin-p42/44MAPK-GEF-H1 complex.","date":"2014","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/24706358","citation_count":34,"is_preprint":false},{"pmid":"24352660","id":"PMC_24352660","title":"Control of vascular permeability by atrial natriuretic peptide via a GEF-H1-dependent mechanism.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24352660","citation_count":34,"is_preprint":false},{"pmid":"23432781","id":"PMC_23432781","title":"Non-centrosomal microtubules regulate F-actin organization through the suppression of GEF-H1 activity.","date":"2013","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/23432781","citation_count":34,"is_preprint":false},{"pmid":"30305100","id":"PMC_30305100","title":"A role for RASSF1A in tunneling nanotube formation between cells through GEFH1/Rab11 pathway control.","date":"2018","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/30305100","citation_count":33,"is_preprint":false},{"pmid":"33762326","id":"PMC_33762326","title":"The Regulatory Subunit PPP2R2A of PP2A Enhances Th1 and Th17 Differentiation through Activation of the GEF-H1/RhoA/ROCK Signaling Pathway.","date":"2021","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/33762326","citation_count":33,"is_preprint":false},{"pmid":"20463241","id":"PMC_20463241","title":"Evidence for the involvement of Lfc and Tctex-1 in axon formation.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20463241","citation_count":32,"is_preprint":false},{"pmid":"20803552","id":"PMC_20803552","title":"Modulation of GEF-H1 induced signaling by heparanase in brain metastatic melanoma cells.","date":"2010","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20803552","citation_count":32,"is_preprint":false},{"pmid":"25107365","id":"PMC_25107365","title":"GEF-H1 controls focal adhesion signaling that regulates mesenchymal stem cell lineage commitment.","date":"2014","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/25107365","citation_count":31,"is_preprint":false},{"pmid":"26152517","id":"PMC_26152517","title":"RalB regulates contractility-driven cancer dissemination upon TGFβ stimulation via the RhoGEF GEF-H1.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26152517","citation_count":31,"is_preprint":false},{"pmid":"22226621","id":"PMC_22226621","title":"GEF-H1/RhoA signalling pathway mediates lipopolysaccharide-induced intercellular adhesion molecular-1 expression in endothelial cells via activation of p38 and NF-κB.","date":"2012","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/22226621","citation_count":29,"is_preprint":false},{"pmid":"28453519","id":"PMC_28453519","title":"Homozygous ARHGEF2 mutation causes intellectual disability and midbrain-hindbrain malformation.","date":"2017","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28453519","citation_count":27,"is_preprint":false},{"pmid":"31481470","id":"PMC_31481470","title":"Claudin-2 suppresses GEF-H1, RHOA, and MRTF, thereby impacting proliferation and profibrotic phenotype of tubular cells.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31481470","citation_count":27,"is_preprint":false},{"pmid":"35896520","id":"PMC_35896520","title":"ARHGEF2/EDN1 pathway participates in ER stress-related drug resistance of hepatocellular carcinoma by promoting angiogenesis and malignant proliferation.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35896520","citation_count":25,"is_preprint":false},{"pmid":"33588881","id":"PMC_33588881","title":"S-1-propenylcysteine improves TNF-α-induced vascular endothelial barrier dysfunction by suppressing the GEF-H1/RhoA/Rac pathway.","date":"2021","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/33588881","citation_count":25,"is_preprint":false},{"pmid":"32789168","id":"PMC_32789168","title":"BNIP-2 retards breast cancer cell migration by coupling microtubule-mediated GEF-H1 and RhoA activation.","date":"2020","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/32789168","citation_count":25,"is_preprint":false},{"pmid":"32107290","id":"PMC_32107290","title":"FAK regulates actin polymerization during sperm capacitation via the ERK2/GEF-H1/RhoA signaling pathway.","date":"2020","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/32107290","citation_count":24,"is_preprint":false},{"pmid":"25738744","id":"PMC_25738744","title":"Interaction between the type III effector VopO and GEF-H1 activates the RhoA-ROCK pathway.","date":"2015","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/25738744","citation_count":24,"is_preprint":false},{"pmid":"20858895","id":"PMC_20858895","title":"Mutant huntingtin alters cell fate in response to microtubule depolymerization via the GEF-H1-RhoA-ERK pathway.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20858895","citation_count":23,"is_preprint":false},{"pmid":"31011918","id":"PMC_31011918","title":"High-grade glioneuronal tumor with an ARHGEF2-NTRK1 fusion gene.","date":"2019","source":"Brain tumor pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31011918","citation_count":22,"is_preprint":false},{"pmid":"27120804","id":"PMC_27120804","title":"Autophagy suppresses cell migration by degrading GEF-H1, a RhoA GEF.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27120804","citation_count":22,"is_preprint":false},{"pmid":"23648943","id":"PMC_23648943","title":"GEF-H1: orchestrating the interplay between cytoskeleton and vesicle trafficking.","date":"2013","source":"Small GTPases","url":"https://pubmed.ncbi.nlm.nih.gov/23648943","citation_count":22,"is_preprint":false},{"pmid":"29972689","id":"PMC_29972689","title":"Rotenone inhibits axonogenesis via an Lfc/RhoA/ROCK pathway in cultured hippocampal neurons.","date":"2018","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29972689","citation_count":20,"is_preprint":false},{"pmid":"36111670","id":"PMC_36111670","title":"Microtubules restrict F-actin polymerization to the immune synapse via GEF-H1 to maintain polarity in lymphocytes.","date":"2022","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/36111670","citation_count":20,"is_preprint":false},{"pmid":"15455375","id":"PMC_15455375","title":"Activation of gef-h1, a guanine nucleotide exchange factor for RhoA, by DNA transfection.","date":"2005","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15455375","citation_count":20,"is_preprint":false},{"pmid":"30846413","id":"PMC_30846413","title":"Increased expression of GEF-H1 promotes colon cancer progression by RhoA signaling.","date":"2019","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/30846413","citation_count":19,"is_preprint":false},{"pmid":"31745977","id":"PMC_31745977","title":"The GEF-H1/PKD3 signaling pathway promotes the maintenance of triple-negative breast cancer stem cells.","date":"2019","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31745977","citation_count":19,"is_preprint":false},{"pmid":"27835861","id":"PMC_27835861","title":"An oncogenic KRAS transcription program activates the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic cancer.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27835861","citation_count":19,"is_preprint":false},{"pmid":"27573018","id":"PMC_27573018","title":"p66Shc Couples Mechanical Signals to RhoA through Focal Adhesion Kinase-Dependent Recruitment of p115-RhoGEF and GEF-H1.","date":"2016","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27573018","citation_count":19,"is_preprint":false},{"pmid":"32692911","id":"PMC_32692911","title":"The RhoA regulators Myo9b and GEF-H1 are targets of cyclic nucleotide-dependent kinases in platelets.","date":"2020","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/32692911","citation_count":18,"is_preprint":false},{"pmid":"28824887","id":"PMC_28824887","title":"GSK-3Beta-Dependent Activation of GEF-H1/ROCK Signaling Promotes LPS-Induced Lung Vascular Endothelial Barrier Dysfunction and Acute Lung Injury.","date":"2017","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/28824887","citation_count":18,"is_preprint":false},{"pmid":"27573550","id":"PMC_27573550","title":"miR-194 is a negative regulator of GEF-H1 pathway in melanoma.","date":"2016","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/27573550","citation_count":17,"is_preprint":false},{"pmid":"21352810","id":"PMC_21352810","title":"GEFH1 binds ASAP1 and regulates podosome formation.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/21352810","citation_count":16,"is_preprint":false},{"pmid":"37193711","id":"PMC_37193711","title":"HUNK inhibits epithelial-mesenchymal transition of CRC via direct phosphorylation of GEF-H1 and activating RhoA/LIMK-1/CFL-1.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37193711","citation_count":16,"is_preprint":false},{"pmid":"33508040","id":"PMC_33508040","title":"Bartonella effector protein C mediates actin stress fiber formation via recruitment of GEF-H1 to the plasma membrane.","date":"2021","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/33508040","citation_count":15,"is_preprint":false},{"pmid":"30902986","id":"PMC_30902986","title":"Microbial recognition by GEF-H1 controls IKKε mediated activation of IRF5.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30902986","citation_count":14,"is_preprint":false},{"pmid":"22949735","id":"PMC_22949735","title":"FAM123A binds to microtubules and inhibits the guanine nucleotide exchange factor ARHGEF2 to decrease actomyosin contractility.","date":"2012","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/22949735","citation_count":14,"is_preprint":false},{"pmid":"29188751","id":"PMC_29188751","title":"Go with the flow: GEF-H1 mediated shear stress mechanotransduction in neutrophils.","date":"2017","source":"Small GTPases","url":"https://pubmed.ncbi.nlm.nih.gov/29188751","citation_count":13,"is_preprint":false},{"pmid":"26359301","id":"PMC_26359301","title":"Dexamethasone-induced cellular tension requires a SGK1-stimulated Sec5-GEF-H1 interaction.","date":"2015","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/26359301","citation_count":13,"is_preprint":false},{"pmid":"35681428","id":"PMC_35681428","title":"Therapeutic Validation of GEF-H1 Using a De Novo Designed Inhibitor in Models of Retinal Disease.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35681428","citation_count":11,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49904,"output_tokens":16062,"usd":0.195321,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":28649,"output_tokens":6039,"usd":0.14711,"stage2_stop_reason":"end_turn"},"total_usd":0.342431,"stage1_batch_id":"msgbatch_015cW3C55o5xm8EPaM1UvcZR","stage2_batch_id":"msgbatch_018NDJHPntdYJzBohpB6hHKo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"Lfc (ARHGEF2) was identified as an oncoprotein containing a Dbl homology (DH) domain in tandem with a pleckstrin homology (PH) domain; deletion analysis showed both PH and DH domains are required for NIH 3T3 transformation, with the PH domain mediating membrane recruitment necessary for transforming activity.\",\n      \"method\": \"Retroviral cDNA transfer, NIH 3T3 transformation assay, NH2- and COOH-terminal deletion analysis, isoprenylation site replacement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct mutagenesis/deletion analysis with functional readout (transformation), replicated by domain replacement\",\n      \"pmids\": [\"7629163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Lfc (ARHGEF2) functions as a highly specific guanine nucleotide exchange factor for RhoA in vitro, catalytically stimulating >10-fold GDP dissociation from RhoA; it forms tight complexes with nucleotide-depleted RhoA and, uniquely, also binds Rac (but not Cdc42 or Ras), distinguishing it from other Dbl-family GEFs.\",\n      \"method\": \"In vitro [3H]GDP dissociation assay, GDP-[35S]GTPγS exchange assay, biochemical pulldown/complex formation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro GEF activity with catalytic demonstration, multiple substrates tested with rigorous controls\",\n      \"pmids\": [\"8910315\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"GEF-H1 (ARHGEF2) stimulates guanine nucleotide exchange on Rac and Rho but not Cdc42, TC10, or Ras; it colocalizes with microtubules through its carboxyl-terminal coiled-coil domain, and overexpression in COS-7 cells induces membrane ruffles.\",\n      \"method\": \"In vitro GEF assay, immunofluorescence colocalization, domain analysis, COS-7 overexpression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro biochemical assay with substrate specificity profiling plus direct localization experiment\",\n      \"pmids\": [\"9857026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Lfc (ARHGEF2) localizes to microtubules via its PH domain interaction with tubulin; overexpression in NIH 3T3 cells induces actin stress fibers and membrane ruffles consistent with RhoA and Rac1 activation, and Lfc stimulates JNK activity in a Rac1-dependent (and partially RhoA-dependent) manner.\",\n      \"method\": \"Immunofluorescence localization, dominant-negative GTPase epistasis, JNK activity assay, GTP-bound Rac measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (localization, epistasis with dominant negatives, kinase assay) in a single study\",\n      \"pmids\": [\"9890991\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"GEF-H1 (ARHGEF2) is regulated by microtubule binding: GEF-H1 mutants deficient in microtubule binding have higher RhoA GEF activity, and drug-induced microtubule depolymerization phenocopies active GEF-H1 expression in a dominant-negative GEF-H1-inhibitable manner, establishing that microtubule-bound GEF-H1 is in an inactive state.\",\n      \"method\": \"Microtubule-binding mutant analysis, nocodazole treatment, dominant-negative GEF-H1 expression, morphology/actin organization assay, gene expression analysis\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mutant analysis plus pharmacological perturbation plus dominant-negative epistasis, replicated across multiple readouts\",\n      \"pmids\": [\"11912491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PAK1 phosphorylates GEF-H1 at Ser885 (within the carboxyl-terminal inhibitory region), inducing 14-3-3 binding to GEF-H1 and relocation of 14-3-3 to microtubules; the carboxyl-terminal coiled-coil region of GEF-H1 is required for microtubule-dependent suppression of its GEF activity.\",\n      \"method\": \"Affinity-based kinase screen, in vitro phosphorylation assay, site-directed mutagenesis, Co-IP/pulldown for 14-3-3 binding, immunofluorescence\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro phosphorylation with mutagenesis identifying specific residue, protein interaction validated by Co-IP\",\n      \"pmids\": [\"14970201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"EPEC effectors EspG and Orf3 interact with tubulin and destabilize microtubules in vitro, thereby releasing GEF-H1 and activating RhoA-ROCK signaling to induce actin stress fibers; dominant-negative GEF-H1 and dominant-negative RhoA (but not Rac1/Cdc42) block EspG/Orf3-induced stress fiber formation.\",\n      \"method\": \"In vitro microtubule destabilization assay, dominant-negative epistasis, ROCK inhibitor treatment, bacterial infection assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro biochemical assay combined with genetic epistasis using dominant-negative constructs\",\n      \"pmids\": [\"15318166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"PAK4 directly associates with GEF-H1 through a novel GEF-H1 interaction domain (GID) in PAK4 and phosphorylates GEF-H1 at Ser810, blocking stress fiber formation while promoting lamellipodia; the endogenous PAK4–GEF-H1 complex associates with microtubules, and PAK4 phosphorylation releases GEF-H1 into the cytoplasm.\",\n      \"method\": \"Co-IP, in vitro phosphorylation, domain mapping, siRNA knockdown, immunofluorescence in NIH-3T3 cells\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro kinase assay with site identification, reciprocal Co-IP, and functional cellular phenotype\",\n      \"pmids\": [\"15827085\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"GEF-H1 (Lfc/ARHGEF2) directly interacts with cingulin (a tight-junction adaptor protein); cingulin binding inhibits GEF-H1 RhoA GEF activity, providing a mechanism by which tight junction formation downregulates RhoA and inhibits G1/S cell cycle progression.\",\n      \"method\": \"Direct binding assay, RNAi knockdown, RhoA activation assay, G1/S phase transition assay in MDCK cells\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct protein interaction with functional GEF inhibition readout plus RNAi epistasis with cell cycle phenotype\",\n      \"pmids\": [\"15866167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Lfc (ARHGEF2) interacts with neurabin and spinophilin via its coiled-coil domain; upon neuronal stimulation, Lfc translocates from dendritic shafts (where it associates with microtubules) to spines, reducing spine length and size through RhoA in a coiled-coil-dependent manner.\",\n      \"method\": \"Yeast two-hybrid, Co-IP, immunofluorescence/live imaging in neurons, domain deletion analysis\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — yeast two-hybrid validated by Co-IP, live-cell localization with functional spine morphology readout\",\n      \"pmids\": [\"15996550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Lfc (ARHGEF2) is required for mitotic spindle assembly during prophase/prometaphase; inhibition of Lfc causes spindle defects and mitotic delay, rescued by constitutively active RhoA, placing Lfc upstream of RhoA in a pathway involving mDia1 for spindle formation.\",\n      \"method\": \"Antibody microinjection/dominant-negative, RhoA rescue epistasis, live-cell microscopy, cell cycle analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with RhoA rescue, multiple approaches (inhibition, rescue, dominant-negative), specific cellular phenotype\",\n      \"pmids\": [\"15976019\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Mutant p53 proteins (V157F, R175H, R248Q) transcriptionally activate GEF-H1 expression, leading to RhoA activation and accelerated tumor cell proliferation; growth of mutant p53 cells depends on GEF-H1 expression whereas wild-type p53 cells do not.\",\n      \"method\": \"Inducible mutant p53 cell lines, expression profiling, RhoA activation assay, siRNA knockdown, cell growth assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — expression profiling plus RhoA activation and knockdown phenotype, single lab\",\n      \"pmids\": [\"16778209\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TRIF-dependent (but not MyD88-dependent) LPS signaling in dendritic cells activates GEF-H1, which in turn activates RhoB (but not RhoA, Rac, or Cdc42); GEF-H1–RhoB drives surface MHCII expression required for CD4+ T cell activation.\",\n      \"method\": \"RNAi knockdown, dominant-negative constructs, Rho activation assays (pull-down), immunofluorescence colocalization, MyD88/TRIF knockout DCs\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout of adaptor proteins, siRNA, dominant-negative epistasis, specific GTPase activity assays with multiple orthogonal approaches\",\n      \"pmids\": [\"16917499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GEF-H1 localizes to the mitotic apparatus (cortical microtubule tips and midbody); Aurora A/B and Cdk1/Cyclin B phosphorylate GEF-H1, inhibiting its catalytic activity during mitosis; dephosphorylation before cytokinesis allows GEF-H1-dependent RhoA GTP-loading at the cleavage furrow, distinct from Ect2-dependent Rho activation.\",\n      \"method\": \"Immunofluorescence localization, in vitro kinase assay (Aurora A/B, Cdk1/Cyclin B), live-cell RhoA biosensor (FRET), siRNA knockdown, GEF-H1 catalytic activity assay\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay identifying writers plus live-cell FRET biosensor for spatiotemporal RhoA activation, multiple orthogonal methods\",\n      \"pmids\": [\"17488622\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GEF-H1 is required and sufficient to mediate nocodazole-induced RhoA activation and cell contractility; siRNA depletion of GEF-H1 prevents nocodazole-induced RhoA activation, ROCK activation, MLC phosphorylation, and cell contraction, rescued by siRNA-resistant GEF-H1 re-expression.\",\n      \"method\": \"siRNA knockdown, rescue with siRNA-resistant GEF-H1, RhoA and ROCK activity assays, MLC phosphorylation western blot, nocodazole treatment\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — siRNA with specific rescue, multiple biochemical readouts of pathway activation\",\n      \"pmids\": [\"18287519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ERK1/2 phosphorylate GEF-H1 at Thr678, enhancing its guanine nucleotide exchange activity toward RhoA; ERK pathway inhibition (PD184352) abolishes this phosphorylation.\",\n      \"method\": \"In vitro ERK1/2 phosphorylation assay, site-directed mutagenesis (Thr678), GEF activity assay, pharmacological ERK inhibition\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with mutagenesis identifying specific residue and functional GEF activity readout, single lab\",\n      \"pmids\": [\"18211802\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GEF-H1 interacts with NOD1 and is required for RIP2-dependent NF-κB activation in response to Shigella effectors IpgB2 and OspB and the NOD1 ligand γTriDAP; GEF-H1 is also required for Shigella cell invasion via RhoA activation.\",\n      \"method\": \"Co-IP (GEF-H1–NOD1 interaction), siRNA knockdown, NF-κB reporter assay, bacterial invasion assay\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP validating protein interaction, siRNA epistasis with both NF-κB and invasion readouts\",\n      \"pmids\": [\"19043560\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Lfc (ARHGEF2) localizes to the Golgi apparatus and growth cones in developing neurons and negatively regulates neurite sprouting and axon formation via RhoA; Tctex-1 (dynein light chain) physically interacts with Lfc, inhibiting its GEF activity, decreasing Rho-GTP, and antagonizing Lfc during neurite formation.\",\n      \"method\": \"Immunofluorescence, Co-IP (Lfc–Tctex-1), RhoA activity assay, siRNA knockdown, axon formation assay\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP validating physical interaction, RhoA activity assay, siRNA knockdown with specific axon phenotype\",\n      \"pmids\": [\"20463241\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Lfc (ARHGEF2) and its negative regulator Tctex-1 determine the balance between proliferative symmetric and neurogenic asymmetric divisions of cortical radial precursors; Lfc knockdown maintains cells as cycling radial precursors while Tctex-1 knockdown promotes neurogenesis; the two proteins regulate mitotic spindle orientation.\",\n      \"method\": \"Morpholino/siRNA knockdown in cortical precursors in vitro and in vivo, lineage tracing, spindle orientation analysis\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo knockdown with coincident double-knockdown epistasis, specific mitotic spindle orientation phenotype\",\n      \"pmids\": [\"19448628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PKA phosphorylates Lfc (ARHGEF2) in an AKAP121-dependent manner; this phosphorylation promotes 14-3-3 binding to Lfc in a phosphorylation-dependent manner and suppresses Lfc exchange activity on RhoA; Tctex-1 competes with 14-3-3 for Lfc binding.\",\n      \"method\": \"Co-IP (Lfc–AKAP121, Lfc–14-3-3), in vitro PKA phosphorylation, forskolin treatment, RhoA GEF activity assay, 14-3-3 binding mutant analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay, protein interaction by Co-IP, functional GEF assay with inhibitory readout, single lab\",\n      \"pmids\": [\"19667072\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"GEF-H1 directly interacts with paracingulin (at epithelial junctions), and paracingulin depletion increases RhoA activity; paracingulin is required for efficient recruitment of GEF-H1 to junctions, linking junction assembly to RhoA regulation.\",\n      \"method\": \"In vitro binding assay, Co-IP, siRNA knockdown, RhoA activation pull-down, immunofluorescence\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vitro binding plus Co-IP plus siRNA with RhoA activity readout, multiple orthogonal methods\",\n      \"pmids\": [\"18653465\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"GEF-H1 interacts with the Y-box transcription factor ZONAB/DbpA; GEF-H1 overexpression induces nuclear ZONAB accumulation and activates ZONAB-dependent transcription; GEF-H1 and ZONAB together are required for RhoA-dependent cyclin D1 expression.\",\n      \"method\": \"Co-IP (GEF-H1–ZONAB), overexpression, cyclin D1 promoter reporter, siRNA knockdown, immunofluorescence\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus reporter assay and siRNA, single lab\",\n      \"pmids\": [\"19730435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"GEF-H1 is a component of the AMPA receptor complex in the brain; it is enriched in the postsynaptic density, colocalizes with GluR1 at spines, and negatively regulates spine density and length through RhoA; AMPA-R-dependent changes in spine morphology are abolished by GEF-H1 knockdown.\",\n      \"method\": \"Co-IP from brain lysate, immunofluorescence, siRNA knockdown, spine morphology analysis, RhoA activity assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP from native brain tissue, siRNA epistasis, direct spine morphology readout\",\n      \"pmids\": [\"19208802\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TNF-α activates GEF-H1 via ERK-mediated phosphorylation of Thr678 in tubular epithelial cells, leading to RhoA activation, MLC phosphorylation, and increased paracellular permeability; GEF-H1 was identified as a TNF-α-activated RhoGEF using a RhoG17A affinity precipitation/mass spectrometry approach.\",\n      \"method\": \"RhoG17A affinity precipitation/mass spectrometry, siRNA knockdown, MEK inhibitor, phospho-specific western blot, permeability assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — unbiased proteomics identification followed by siRNA epistasis and pharmacological pathway dissection with multiple readouts\",\n      \"pmids\": [\"19261619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TGF-β transcriptionally upregulates GEF-H1 in a Smad4-dependent manner in RPE cells; GEF-H1 induction leads to RhoA activation and is required for TGF-β-induced α-SMA expression and cell migration.\",\n      \"method\": \"Genome-wide expression analysis, Smad4-dependent transcription assay, GEF-H1 siRNA knockdown, RhoA activity assay, cell migration assay\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide expression screen identifying GEF-H1 as unique RhoGEF upregulated, Smad4 dependence, siRNA epistasis with functional readouts\",\n      \"pmids\": [\"20089843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Lfc (ARHGEF2) and p114-RhoGEF mediate Wnt-3a/Dishevelled-induced RhoA activation and neurite retraction; Lfc and p114-RhoGEF physically bind Dvl and Daam1, and their knockdown suppresses Dvl- and Wnt-3a-induced RhoA activation and neurite retraction.\",\n      \"method\": \"shRNA screen, Co-IP (Lfc–Dvl, Lfc–Daam1), RhoA activation assay, neurite retraction assay in N1E-115 cells\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — shRNA screen validated by Co-IP and functional RhoA activation/phenotype assays\",\n      \"pmids\": [\"20810787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Mechanical force on integrins triggers GEF-H1 catalytic activation via ERK downstream of a FAK–Ras signaling cascade, and recruits GEF-H1 to adhesion complexes; this is distinct from LARG activation (which occurs via Fyn), and both GEFs are required for force-induced cellular stiffening (reinforcement).\",\n      \"method\": \"Magnetic bead force application, biochemical fractionation, GEF activity assay, siRNA knockdown, traction force microscopy\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — biophysical force application combined with biochemical GEF activity assay and siRNA epistasis, multiple orthogonal approaches\",\n      \"pmids\": [\"21572419\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GEF-H1 is required for NOD2- and RIP2-dependent NF-κB activation; GEF-H1 functions downstream of NOD2 as part of RIP2-containing signaling complexes and mediates Src tyrosine kinase-dependent phosphorylation of RIP2; the 3020insC NOD2 variant associated with Crohn's disease fails to activate this GEF-H1-dependent pathway.\",\n      \"method\": \"siRNA knockdown, Co-IP (GEF-H1–RIP2–NOD2), NF-κB reporter assay, confocal microscopy, macrophage activation assay\",\n      \"journal\": \"Inflammatory bowel diseases\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP validating complex, siRNA epistasis, disease-variant specificity tested\",\n      \"pmids\": [\"21887730\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PAR1b/MARK2 phosphorylates GEF-H1 at Ser885 and Ser959, inhibiting GEF-H1 RhoA-specific GEF activity and suppressing stress fiber formation; Par1b-phosphorylated GEF-H1 loses the ability to activate RhoA.\",\n      \"method\": \"In vitro kinase assay, phosphorylation site mutagenesis, RhoA GEF activity assay, stress fiber formation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with specific site mutagenesis and functional GEF activity readout\",\n      \"pmids\": [\"22072711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Par1b/MARK2 phosphorylates GEF-H1 at multiple conserved serine residues, releasing GEF-H1 from microtubules and abrogating GEF-H1-induced microtubule stabilization/acetylation; non-phosphorylatable GEF-H1 (3SA mutant) remains statically bound to microtubules as visualized by live-cell imaging.\",\n      \"method\": \"In vitro kinase assay, immunofluorescence, live-cell time-lapse imaging of GFP-GEF-H1, microtubule acetylation assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro kinase assay, phosphomutant live imaging, functional microtubule readout\",\n      \"pmids\": [\"21513698\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Calpain-6 (CAPN6) co-localizes and physically interacts with GEF-H1 on microtubules; CAPN6 knockdown causes GEF-H1 to translocate from microtubules to the lamellipodial region and interact with Rac1, leading to Rac1 activation, increased cell migration, and lamellipodial protrusion; this Rac1 activation requires GEF-H1.\",\n      \"method\": \"siRNA knockdown, Co-IP (CAPN6–GEF-H1), immunofluorescence, Rac1 and RhoA activity assays, migration assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP plus siRNA double knockdown epistasis plus Rac/RhoA activity assays\",\n      \"pmids\": [\"21406564\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"GEF-H1 directly binds exocyst component Sec5 in a RalA GTPase-dependent manner; this interaction promotes RhoA activation, regulates exocyst assembly/localization, and is required for exocytosis.\",\n      \"method\": \"Direct binding assay (pulldown), Co-IP (GEF-H1–Sec5, RalA-dependence), RhoA activation assay, exocytosis assay, siRNA knockdown\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct pulldown plus Co-IP, RalA-dependency established, functional exocytosis assay\",\n      \"pmids\": [\"22898781\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Non-centrosomal microtubules anchored by CAMSAP3 (Nezha) preferentially sequester GEF-H1; CAMSAP3 depletion increases the soluble pool of GEF-H1, upregulates RhoA activity, and promotes actin stress fiber formation; detyrosinated microtubules do not efficiently interact with GEF-H1.\",\n      \"method\": \"siRNA knockdown, RhoA activity assay, immunofluorescence, subcellular fractionation\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA with RhoA activity readout and fractionation, single lab, moderate methods\",\n      \"pmids\": [\"23432781\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"GEFH1 binds the BAR domain of ASAP1 (validated by endogenous Co-IP) and colocalizes with ASAP1 in podosomes; GEFH1 overexpression inhibits podosome assembly and ASAP1 GAP activity, while GEFH1 knockdown increases podosome assembly rate.\",\n      \"method\": \"Yeast two-hybrid, endogenous Co-IP, siRNA knockdown, overexpression, podosome assembly assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — endogenous Co-IP plus functional podosome assays, single lab\",\n      \"pmids\": [\"21352810\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Microtubule stability is diminished by a stiff 3D extracellular matrix, leading to activation of GEF-H1 and RhoA; GEF-H1 loss decreases cell contraction and invasion through 3D matrices; MEK/ERK pathway does not contribute to stiffness-induced GEF-H1 activation in this context.\",\n      \"method\": \"3D matrix stiffness assay, microtubule stability assay, GEF-H1 siRNA, RhoA activity assay, cell contraction/invasion assay\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA with RhoA activity and functional invasion readout, single lab\",\n      \"pmids\": [\"22593214\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GEF-H1 is essential for RIG-I-like receptor sensing of foreign RNA; upon microtubule release GEF-H1 activation controls RIG-I- and Mda5-dependent IRF3 phosphorylation and IFN-β induction; Arhgef2−/− mice show pronounced antiviral signaling defects against encephalomyocarditis virus and influenza A virus.\",\n      \"method\": \"Arhgef2 knockout mouse generation, viral challenge, IRF3 phosphorylation assay, IFN-β induction assay, siRNA knockdown in macrophages\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout mouse with in vivo viral challenge and biochemical pathway readouts, multiple orthogonal methods\",\n      \"pmids\": [\"24270516\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TNF-α sequentially activates Rac (via GEF-H1 phosphorylation at S885) and then RhoA (via GEF-H1 T678 phosphorylation) through a single exchange factor; GEF-H1-mediated Rac activation drives TACE/ADAM17, which transactivates EGFR/ERK and leads to T678 phosphorylation and RhoA activation.\",\n      \"method\": \"siRNA knockdown, phospho-specific western blots (T678, S885 mutants), Rac and RhoA activity assays, TACE activity assay\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — phosphosite-specific mutants, siRNA epistasis, sequential activation assays with multiple GTPase readouts\",\n      \"pmids\": [\"23389627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GEF-H1 acts as an adaptor linking PP2A B' subunits to the scaffold protein KSR-1, mediating dephosphorylation of KSR-1 S392 and activating MAPK signaling downstream of oncogenic RAS; this role is independent of GEF-H1's RhoGEF catalytic activity.\",\n      \"method\": \"Co-IP (GEF-H1–KSR-1–PP2A), phosphorylation assay, GEF-H1 catalytic mutant analysis, siRNA knockdown, tumor xenograft growth assay\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP establishing ternary complex, catalytic mutant confirming non-GEF mechanism, xenograft functional readout\",\n      \"pmids\": [\"24525234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"MARK3 (activated by LKB1) phosphorylates ARHGEF2 at Ser151, generating a 14-3-3 binding site that disrupts the ARHGEF2–DYNLT1 (Tctex-1) interaction and dissociates ARHGEF2 from microtubules; this stimulates RhoA activation and stress fiber/focal adhesion formation; PP2A dephosphorylates Ser151 to restore the inhibited state.\",\n      \"method\": \"In vitro kinase assay (MARK3), Co-IP (ARHGEF2–DYNLT1, ARHGEF2–14-3-3), site-directed mutagenesis (S151), 3D culture architecture assay, phosphatase assay\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay with mutagenesis, reciprocal Co-IP, PP2A eraser identified, functional 3D culture phenotype\",\n      \"pmids\": [\"29089450\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RASSF1A stimulates cofilin/PP2A-mediated dephosphorylation of GEF-H1, thereby activating GEF-H1 to activate the antimetastatic GTPase RhoB; RASSF1A loss reduces GEF-H1-mediated RhoB activation and increases nuclear YAP, promoting EMT and invasion.\",\n      \"method\": \"RNAi silencing, Co-IP, PP2A/cofilin phosphatase assay, RhoB activation assay, in vivo metastasis assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and phosphatase assay establishing mechanism, single lab\",\n      \"pmids\": [\"26759237\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GEF-H1 mediates GEF-H1/RhoA activation induced by LPA or thrombin (GPCR ligands) through a mechanism independent of microtubule depolymerization: Gα directly binds GEF-H1 and displaces it from Tctex-1, while Gβγ binds Tctex-1 and disrupts its dynein intermediate chain interaction; full GEF-H1 activation requires subsequent PP2A-mediated dephosphorylation of Ser885.\",\n      \"method\": \"Co-IP (GEF-H1–Tctex-1–dynein, Gα–GEF-H1, Gβγ–Tctex-1), direct binding assay, GEF-H1 activity assay, phosphatase assay, LPA/thrombin stimulation\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct protein interaction mapping with multiple Co-IPs, in vitro GEF assay, phosphatase identification, multiple orthogonal methods\",\n      \"pmids\": [\"25209408\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GEF-H1 functions in apical constriction and cell intercalation during Xenopus neural tube closure; GEF-H1 depletion (morpholino) causes neural tube defects with impaired MLC phosphorylation, Rab11 and F-actin accumulation; overexpressed GEF-H1 induces ROCK-dependent ectopic apical constriction.\",\n      \"method\": \"Morpholino knockdown, RNA rescue, lineage tracing, MLC phosphorylation assay, ROCK inhibitor, immunofluorescence in Xenopus embryo\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — morpholino knockdown with mRNA rescue in vivo, ROCK inhibitor epistasis, multiple molecular readouts\",\n      \"pmids\": [\"24681784\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"VopO, a Vibrio parahaemolyticus type III effector, directly binds GEF-H1 via an alpha-helix region; this interaction is required for T3SS2-dependent RhoA-ROCK pathway activation and stress fiber formation; GEF-H1 binding activity of VopO correlates with its stress fiber-inducing and epithelial barrier disruption capacity.\",\n      \"method\": \"Direct pulldown (VopO–GEF-H1), Co-IP, deletion/mutagenesis mapping, RhoA activity assay, transepithelial resistance measurement\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct binding with mutagenesis establishing interaction domain, functional epistasis with GEF-H1 knockdown\",\n      \"pmids\": [\"25738744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RalB (but not RalA) promotes TGFβ-induced cancer cell dissemination via GEF-H1; RalB acts through the exocyst subunit Sec5 to promote GEF-H1-dependent RhoA activation and actomyosin contractility; uncoupling Sec5 from GEF-H1 impairs RhoA activation and traction force generation.\",\n      \"method\": \"Co-IP (GEF-H1–Sec5), siRNA knockdown (RalA vs RalB), traction force microscopy, RhoA activation assay, 3D dissemination assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP, traction force microscopy, siRNA epistasis with specific GTPase readouts\",\n      \"pmids\": [\"26152517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The TRPC3 channel mediates mechanical stress/TGFβ-induced GEF-H1 activation in cardiomyocytes and cardiac fibroblasts; TRPC3 functionally interacts with microtubule-associated Nox2, and Nox2 inhibition attenuates mechanical stretch-induced GEF-H1 activation; TRPC3 inhibition suppresses GEF-H1-mediated RhoA activation and fibrotic responses.\",\n      \"method\": \"Proteomics (TRPC3 interactome), Nox2 inhibitor studies, GEF-H1 activation assay, fibrosis assays in cardiomyocytes/fibroblasts, pressure-overload mouse model\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — proteomics identification plus pharmacological inhibition, single lab\",\n      \"pmids\": [\"27991560\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Autophagy degrades GEF-H1 via a p62-dependent mechanism; in autophagy-deficient cells (Atg5/Atg7/Ulk1 KO), GEF-H1 accumulates, RhoA activity increases, and cells switch to amoeboid migration; GEF-H1 silencing in Atg5 KO cells reverts this phenotype.\",\n      \"method\": \"Co-IP (GEF-H1–p62), Atg5/Atg7/Ulk1 knockout MEFs, GEF-H1 silencing rescue, RhoA activity assay, cell migration assay\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple autophagy-deficient genetic models, Co-IP for p62 interaction, siRNA rescue, RhoA activity assay\",\n      \"pmids\": [\"27120804\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PP2A regulatory subunit PPP2R2A binds, dephosphorylates, and activates GEF-H1 at Ser885, leading to increased RhoA-GTP levels and ROCK activity in T cells, promoting Th1 and Th17 differentiation.\",\n      \"method\": \"Co-IP (PPP2R2A–GEF-H1), phospho-Ser885 western blot, RhoA activity assay, T cell conditional knockout, Th1/Th17 differentiation assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP, phosphatase-specific dephosphorylation readout, conditional KO with specific T cell phenotype\",\n      \"pmids\": [\"33762326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Vimentin intermediate filaments regulate actin stress fiber assembly via GEF-H1; vimentin loss induces phosphorylation of GEF-H1 at Ser886, promoting RhoA activity and stress fiber assembly; this requires intact vimentin filaments (not unit-length forms).\",\n      \"method\": \"Vimentin knockout cells, wild-type vs non-filamentous vimentin rescue, Ser886 phosphorylation western blot, RhoA activity assay, MLC phosphorylation assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with specific rescue distinguishing filament requirement, phospho-site specific readout, RhoA activity assay\",\n      \"pmids\": [\"28096473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Homozygous frameshift mutation in ARHGEF2 causes intellectual disability and midbrain-hindbrain malformation; loss of ARHGEF2 perturbs progenitor cell differentiation, shifts mitotic spindle plane orientation toward symmetric divisions, and reduces RhoA/ROCK/MLC pathway activation; Arhgef2 mutant mice recapitulate the human malformation with aberrant precerebellar neuron migration.\",\n      \"method\": \"Whole exome sequencing, Arhgef2 knockout/mutant mouse, spindle orientation analysis, MLC phosphorylation assay, neuronal migration assay\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — human genetics validated in mouse model with cellular mechanism (spindle orientation, RhoA pathway), multiple readouts\",\n      \"pmids\": [\"28453519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GEF-H1 contains an autoinhibitory sequence; live-cell biosensor imaging reveals that autoinhibited GEF-H1 localizes to microtubules, while MT depolymerization at the cell cortex activates GEF-H1 in a ~5-µm peripheral band; Src phosphorylation activates GEF-H1 in a narrower ~0-2 µm band at the cell edge in coordination with protrusions.\",\n      \"method\": \"GEF-H1 activation FRET biosensor, live-cell simultaneous imaging of MT dynamics and GEF-H1 activity, Src inhibitor treatment, autoinhibitory sequence mapping\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — novel biosensor enabling spatiotemporal GEF-H1 activity mapping, autoinhibitory domain identification, pharmacological validation\",\n      \"pmids\": [\"31420453\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GEF-H1 is specifically released upon microtubule destabilization in dendritic cells and drives DC maturation via JNK pathway and AP-1/ATF transcriptional response; GEF-H1 promotes cross-presentation of tumor antigens to CD8 T cells; Arhgef2−/− mice show impaired anti-tumor immunity.\",\n      \"method\": \"Arhgef2 knockout mice, DC maturation assay, JNK activity assay, antigen cross-presentation assay, in vivo tumor challenge\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with in vivo tumor challenge, JNK/AP-1 pathway dissection, cross-presentation functional assay\",\n      \"pmids\": [\"31553907\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GEF-H1 is required for IKKε-mediated phosphorylation and activation of IRF5 in response to microbial muramyl-dipeptides; GEF-H1 functions in a microtubule-based peptidoglycan recognition system independent of NOD-like receptors; deletion or dominant-negative GEF-H1 prevents IKKε and IRF5 activation and host defenses against Listeria monocytogenes.\",\n      \"method\": \"GEF-H1 knockout/dominant-negative, IKKε kinase assay, IRF5 phosphorylation assay, Listeria infection model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic tools (KO, dominant-negative), in vitro kinase assay, in vivo infection model with multiple biochemical readouts\",\n      \"pmids\": [\"30902986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"BNIP-2 (a BCH domain protein) binds both GEF-H1 and RhoA and traffics with kinesin-1 on microtubules; upon microtubule disassembly, the BNIP-2–GEF-H1 interaction increases and BNIP-2 scaffolds GEF-H1–RhoA coupling; BNIP-2 depletion reduces RhoA activation and cell rounding after nocodazole treatment.\",\n      \"method\": \"Co-IP (BNIP-2–GEF-H1, BNIP-2–RhoA), kinesin-1 trafficking assay, siRNA knockdown, RhoA activity assay, live-cell imaging\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP establishing ternary complex, siRNA epistasis, RhoA activity assay, microtubule disassembly context\",\n      \"pmids\": [\"32789168\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PKA and PKG phosphorylate GEF-H1 at Ser886 in platelets, stimulating 14-3-3β binding and promoting GEF-H1 association with microtubules, thereby inhibiting GEF-H1 GEF function; microtubule disruption increases RhoA-GTP levels in platelets, confirming GEF-H1's role in platelet RhoA regulation.\",\n      \"method\": \"Phosphoproteomics, western blot (Ser886 phosphorylation), Phos-tag gel, 14-3-3 binding pulldown, microtubule disruption assay, RhoA-GTP pulldown\",\n      \"journal\": \"Journal of thrombosis and haemostasis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phosphoproteomics plus functional pulldown and RhoA activity assay, single lab\",\n      \"pmids\": [\"32692911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"YTHDF1 binds m6A sites on ARHGEF2 mRNA, enhancing ARHGEF2 translation; increased ARHGEF2 protein activates RhoA signaling and promotes CRC tumor growth and metastasis; siRNA-LNP delivery targeting ARHGEF2 suppresses tumor growth in vivo.\",\n      \"method\": \"m6A-MeRIP-seq, YTHDF1 RIP-seq, proteomics, Ythdf1 knockout mouse (inflammatory CRC model), rescue with ARHGEF2 overexpression, siRNA-LNP in vivo treatment\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiomics defining m6A-YTHDF1-ARHGEF2 axis, genetic KO mouse, in vitro/in vivo rescue, siRNA therapeutic validation\",\n      \"pmids\": [\"34968454\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Glutamine deficiency triggers macropinocytosis in pancreatic cancer-associated fibroblasts via CaMKK2-AMPK signaling and ARHGEF2; ARHGEF2 is required for this stromal macropinocytic response, which supplies amino acids to both CAFs and tumor cells.\",\n      \"method\": \"siRNA/shRNA knockdown of ARHGEF2, CaMKK2-AMPK inhibition, macropinocytosis assay (imaging), amino acid measurement, xenograft tumor growth assay\",\n      \"journal\": \"Cancer discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with functional macropinocytosis and tumor growth readout, single lab\",\n      \"pmids\": [\"33653692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NEK9 directly phosphorylates ARHGEF2, activating RhoA and promoting gastric cancer cell motility; NEK9 is transcriptionally suppressed by miR-520f-3p, which is itself repressed by IL-6/STAT3 signaling, placing ARHGEF2 phosphorylation downstream of the IL-6-STAT3-NEK9 pathway.\",\n      \"method\": \"In vitro kinase assay (NEK9→ARHGEF2), GST pulldown, Co-IP, phosphoproteomics, miR-520f-3p luciferase reporter, ChIP, RhoA activation assay\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro kinase assay identifying NEK9 as ARHGEF2 kinase, phosphoproteomics, multiple orthogonal pathway validation methods\",\n      \"pmids\": [\"33500736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Bartonella effector BepC binds GEF-H1 via its N-terminal FIC domain (in a non-catalytic manner) and re-localizes GEF-H1 from microtubules to the plasma membrane; this GEF-H1-dependent mechanism activates RhoA/ROCK and triggers actin stress fiber formation and cell fragmentation in migrating endothelial cells.\",\n      \"method\": \"Interactomic analysis (Co-IP/MS), GEF-H1 knockout cell lines, BepC domain mapping/mutagenesis, ROCK inhibitor, immunofluorescence\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — interactomics plus genetic KO cells, BepC domain mutagenesis, pharmacological pathway confirmation\",\n      \"pmids\": [\"33508040\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Peptide inhibitors designed against the GEF-H1 autoregulatory C-terminal domain block RhoA/GEF-H1 binding in vitro and inhibit GEF-H1-dependent TGFβ-induced fibrosis, LPS-stimulated endothelial barrier disruption, and cell migration; the most potent inhibitor inhibits blood vessel leakage and retinal inflammation in an in vivo retinal disease model.\",\n      \"method\": \"In silico peptide design, in vitro RhoA/GEF-H1 binding assay, cell-based permeability and migration assays, in vivo retinal disease mouse model\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro biochemical blocking assay, in vivo validation, but peptide tool compounds with modest mechanistic novelty\",\n      \"pmids\": [\"35681428\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HUNK kinase directly phosphorylates GEF-H1 at Ser645, which activates RhoA and leads to cascading phosphorylation of LIMK-1/CFL-1, stabilizing F-actin and inhibiting EMT in colorectal cancer.\",\n      \"method\": \"In vitro kinase assay (HUNK→GEF-H1 S645), phospho-specific western blot, RhoA/LIMK-1/CFL-1 activity assays, siRNA/overexpression in CRC cells, in vivo metastasis model\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay identifying specific phosphorylation site, downstream pathway cascade validated, in vivo functional readout\",\n      \"pmids\": [\"37193711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"FAM123A binds to ARHGEF2 via a microtubule-associated interaction, and this binding inhibits ARHGEF2 GEF activity; FAM123A depletion increases actomyosin contractility, focal adhesion size, and decreases cell migration in an ARHGEF2-dependent manner.\",\n      \"method\": \"Affinity purification/mass spectrometry, domain interaction assay, siRNA knockdown, actomyosin contractility assay, focal adhesion size measurement, cell migration assay\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — MS-defined interaction with siRNA epistasis and functional readout, single lab\",\n      \"pmids\": [\"22949735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"hPTTG1 transcriptionally activates GEF-H1 gene expression by directly binding and activating the GEF-H1 promoter (validated by luciferase reporter and ChIP); hPTTG1 knockdown decreases GEF-H1 expression and RhoA activation, reducing breast cancer cell motility and invasion, rescued by GEF-H1 re-expression.\",\n      \"method\": \"Luciferase reporter assay, ChIP assay, siRNA knockdown, RhoA activity assay, invasion/migration assay, in vivo metastasis model\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP plus luciferase reporter establishing direct transcriptional regulation, siRNA with in vivo rescue\",\n      \"pmids\": [\"22002306\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Tension on JAM-A activates RhoA via GEF-H1 (and p115 RhoGEF) through PI3K-mediated GEF-H1 activation; FAK/ERK further regulate GEF-H1; phosphorylation of JAM-A at Ser284 is required for this RhoA activation in response to tension.\",\n      \"method\": \"Magnetic bead tension application, PI3K inhibitor, siRNA knockdown of GEF-H1 and p115, RhoA activity assay, JAM-A phospho-mutant analysis\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — force application with siRNA epistasis and RhoA activity readout, single lab\",\n      \"pmids\": [\"26985018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ONCOGENIC KRAS transcriptionally activates ARHGEF2 through a minimal RAS-responsive promoter regulated by ELK1, ETS1, SP1, SP3 (positive) and RREB1 (negative); RREB1 knockdown increases ARHGEF2 expression and extends RhoA activation duration; ARHGEF2 rescues SP3 loss-of-function invasion/migration defects.\",\n      \"method\": \"Promoter reporter assay, transcription factor ChIP/knockdown, ARHGEF2 overexpression rescue, RhoA activation assay, invasion/migration assay\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter reporter and siRNA epistasis with functional readouts, single lab\",\n      \"pmids\": [\"27835861\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ARHGEF2/GEF-H1 is a RhoA (and to a lesser extent Rac1) guanine nucleotide exchange factor that is held in an inactive, autoinhibited state when bound to polymerized microtubules via its coiled-coil domain; microtubule depolymerization, or displacement by binding partners (Gα subunits, Bartonella BepC, RalA–Sec5), releases GEF-H1 and allows RhoA activation that drives actin stress fiber formation, cell contractility, cytokinesis, barrier regulation, and innate immune signaling. GEF-H1 activity is further tuned by a network of phosphorylation events: PAK1, PAK4, ERK1/2, Aurora A/B, Cdk1, MARK2/PAR1b, MARK3 (LKB1-activated), NEK9, PKA/PKG, and HUNK each phosphorylate distinct GEF-H1 residues (notably Ser885/886, Thr678, Ser151, Ser645, Ser810, Ser959) to either inhibit (by creating 14-3-3 binding sites that tether GEF-H1 to microtubules) or activate (by enhancing exchange activity) the protein, while PP2A dephosphorylates Ser885 and Ser151 to restore activity; GEF-H1 also acts as a non-catalytic adaptor linking PP2A to KSR-1 for MAPK activation, interacts with NOD1/NOD2–RIP2 complexes for NF-κB and IRF5 innate immune signaling, and is sequestered at tight junctions by cingulin and paracingulin to control epithelial RhoA activity and proliferation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ARHGEF2 (GEF-H1/Lfc) is a Dbl-family guanine nucleotide exchange factor that catalytically and specifically activates RhoA (and to a lesser extent Rac1) to drive actin stress fiber formation, cell contractility, mitotic spindle assembly, epithelial barrier regulation, and innate immune signaling [#1, #2, #3]. Its activity is gated by microtubule binding through its C-terminal coiled-coil region: microtubule-associated GEF-H1 is held in an autoinhibited state, and microtubule depolymerization or release from the cytoskeleton liberates active GEF-H1 to load GTP onto RhoA [#4, #14, #49]. Release is achieved by diverse inputs — drug-induced or mechanically/matrix-stiffness-induced microtubule destabilization [#14, #34], displacement by G\\u03b1 subunits and RalA\\u2013Sec5 exocyst coupling downstream of GPCR ligands [#40, #31], and bacterial effectors (EPEC EspG/Orf3, Vibrio VopO, Bartonella BepC) that destabilize microtubules or directly bind and relocalize GEF-H1 to activate RhoA-ROCK signaling [#6, #42, #57]. A dense phosphoregulatory network tunes the protein: phosphorylation by PAK1, PAK4, PAR1b/MARK2, MARK3, PKA/PKG creates 14-3-3 binding sites that tether GEF-H1 to microtubules and suppress exchange activity, while ERK (Thr678), NEK9, and HUNK (Ser645) phosphorylation enhance activity; PP2A reverses inhibitory phosphorylation at Ser885/Ser151 to restore activity [#5, #7, #28, #38, #15, #56, #59, #46, #40]. GEF-H1 is sequestered at tight junctions by cingulin and paracingulin to restrain epithelial RhoA and G1/S progression [#8, #20], and is essential for RhoA-dependent mitotic spindle assembly and cleavage-furrow Rho activation during cytokinesis [#10, #13]. Beyond its catalytic role, GEF-H1 acts as a non-catalytic adaptor linking PP2A to the scaffold KSR-1 to activate MAPK downstream of oncogenic RAS [#37], and is required for innate immune signaling through NOD1/NOD2\\u2013RIP2 to NF-\\u03baB, RIG-I/Mda5 to IRF3/IFN-\\u03b2, and an IKK\\u03b5\\u2013IRF5 peptidoglycan-sensing pathway [#16, #27, #35, #51]. Homozygous frameshift mutation in ARHGEF2 causes intellectual disability and midbrain-hindbrain malformation, with loss shifting mitotic spindle orientation toward symmetric divisions and reducing RhoA/ROCK/MLC signaling [#48].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established that ARHGEF2 is a catalytically active, substrate-selective exchange factor, defining its core biochemical identity.\",\n      \"evidence\": \"In vitro GDP dissociation and GTP\\u03b3S exchange assays with RhoA, Rac, Cdc42, and Ras\",\n      \"pmids\": [\"8910315\", \"9857026\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular triggers of exchange activity not yet defined\", \"Relative physiological weight of RhoA vs Rac activity unresolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Linked GEF activity to a cytoskeletal localization, showing GEF-H1 acts on RhoA/Rac to remodel actin and signal to JNK.\",\n      \"evidence\": \"Immunofluorescence localization, dominant-negative GTPase epistasis, and JNK assays in NIH 3T3 cells\",\n      \"pmids\": [\"9890991\", \"7629163\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism coupling microtubule localization to activity state not established\", \"Domain basis of autoinhibition unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defined the central regulatory logic: microtubule-bound GEF-H1 is inactive and microtubule depolymerization activates RhoA, resolving how cytoskeletal state controls exchange activity.\",\n      \"evidence\": \"Microtubule-binding mutants, nocodazole treatment, and dominant-negative epistasis with morphology readouts\",\n      \"pmids\": [\"11912491\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular nature of the autoinhibited conformation not defined\", \"How depolymerization is sensed and transmitted unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Revealed phosphorylation-coupled 14-3-3 binding as the molecular switch tethering GEF-H1 to microtubules, and PAK4 as a writer producing alternative (lamellipodial) outputs.\",\n      \"evidence\": \"In vitro kinase assays (PAK1 Ser885, PAK4 Ser810), site mutagenesis, and 14-3-3 Co-IP\",\n      \"pmids\": [\"14970201\", \"15827085\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Erasers restoring active state not yet identified\", \"Stoichiometry and combinatorial logic of multisite phosphorylation unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrated regulated sequestration by binding partners (cingulin, neurabin/spinophilin) couples GEF-H1-RhoA to tight-junction and synaptic morphology, extending its role beyond microtubules.\",\n      \"evidence\": \"Direct binding, Co-IP, RNAi, and morphology/cell cycle readouts in MDCK cells and neurons\",\n      \"pmids\": [\"15866167\", \"15996550\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether junction and microtubule pools are exchangeable not resolved\", \"Quantitative contribution of each sequestering partner unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Placed GEF-H1 in cell-cycle control, showing mitotic kinases inhibit it and timed dephosphorylation enables furrow RhoA activation distinct from Ect2.\",\n      \"evidence\": \"In vitro Aurora A/B and Cdk1/CyclinB kinase assays, FRET RhoA biosensor, and siRNA in mitotic cells\",\n      \"pmids\": [\"17488622\", \"15976019\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphatase timing the mitotic-exit activation not pinned down\", \"Spatial coordination with Ect2 not fully mapped\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Established GEF-H1 as the necessary and sufficient transducer of microtubule depolymerization into RhoA-ROCK-MLC contractility, and identified ERK (Thr678) as an activating writer.\",\n      \"evidence\": \"siRNA with rescue, RhoA/ROCK/MLC readouts, and in vitro ERK phosphorylation with mutagenesis\",\n      \"pmids\": [\"18287519\", \"18211802\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How activating versus inhibitory phosphorylation are integrated unclear\", \"Upstream signals selecting ERK input not defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Expanded GEF-H1 into innate immunity, GPCR-linked transcription, and inhibitory adaptors, showing it transduces pathogen and receptor signals to RhoA/RhoB and gene expression.\",\n      \"evidence\": \"NOD1 Co-IP/NF-\\u03baB reporter, TRIF-dependent RhoB activation in DCs, ZONAB/cyclin D1 reporter, Tctex-1/AKAP121-PKA, paracingulin binding\",\n      \"pmids\": [\"19043560\", \"16917499\", \"19730435\", \"19667072\", \"20463241\", \"18653465\", \"19208802\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"GTPase selectivity (RhoA vs RhoB vs Rac) per stimulus not mechanistically explained\", \"How the same GEF reaches distinct downstream programs unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showed mechanical force and additional kinases/partners (PAR1b/MARK2, CAPN6) reroute GEF-H1 output between RhoA and Rac, linking it to mechanotransduction and adhesion reinforcement.\",\n      \"evidence\": \"Magnetic bead force with GEF assays, in vitro MARK2 kinase assays, and CAPN6 Co-IP/siRNA with Rac1 activation\",\n      \"pmids\": [\"21572419\", \"22072711\", \"21513698\", \"21406564\", \"21887730\", \"22002306\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants of RhoA-versus-Rac choice at adhesions unclear\", \"Integration of force and phosphorylation inputs not quantitatively modeled\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified non-microtubule scaffolds (Sec5/RalA exocyst, ASAP1, FAM123A, CAMSAP3) that localize and gate GEF-H1, broadening its role into exocytosis and non-centrosomal microtubule control.\",\n      \"evidence\": \"Direct binding/Co-IP, RalA-dependency tests, siRNA with RhoA/Rac activity and exocytosis/podosome readouts\",\n      \"pmids\": [\"22898781\", \"21352810\", \"22949735\", \"23432781\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Several interactions rest on single-lab Co-IP/MS without reciprocal in vivo validation\", \"Hierarchy among competing sequestering partners unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defined GEF-H1 as a master antiviral sensor and showed a single GEF can sequentially activate Rac then RhoA via distinct phosphosites in cytokine signaling.\",\n      \"evidence\": \"Arhgef2 knockout mice with viral challenge and IRF3/IFN-\\u03b2 readouts; phosphosite-mutant Rac/RhoA activation assays for TNF-\\u03b1\",\n      \"pmids\": [\"24270516\", \"23389627\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis distinguishing Rac- versus RhoA-directed conformations unresolved\", \"How microtubule release links to RNA sensing mechanistically unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Uncovered a catalysis-independent adaptor function (PP2A\\u2013KSR-1\\u2013MAPK) and defined a MARK3/LKB1\\u2013PP2A writer-eraser pair at Ser151, plus GPCR-driven activation via G\\u03b1/G\\u03b2\\u03b3 displacement of Tctex-1.\",\n      \"evidence\": \"Co-IP of ternary complexes, GEF-catalytic-dead mutants, in vitro MARK3 kinase assay, and direct G-protein binding with phosphatase assays\",\n      \"pmids\": [\"24525234\", \"29089450\", \"25209408\", \"26759237\", \"24681784\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the adaptor versus catalytic modes not resolved\", \"How PP2A is targeted to specific GEF-H1 sites unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showed protein turnover (autophagy/p62) and stiffness/channel signaling (TRPC3-Nox2) regulate GEF-H1 abundance and activity, controlling migration mode and fibrotic responses.\",\n      \"evidence\": \"Autophagy-deficient knockouts with p62 Co-IP, TRPC3 interactomics/inhibition, and JAM-A tension experiments\",\n      \"pmids\": [\"27120804\", \"27991560\", \"26985018\", \"33762326\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals selecting degradation versus phosphoregulation unknown\", \"TRPC3-Nox2 mechanism rests on single-lab pharmacology\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Provided spatiotemporal resolution of activation and extended innate roles, mapping autoinhibited microtubule pool versus cortically activated pools and IKK\\u03b5\\u2013IRF5 and DC cross-presentation functions.\",\n      \"evidence\": \"GEF-H1 FRET biosensor with live MT imaging, Src inhibition, and Arhgef2 knockout immune/infection models\",\n      \"pmids\": [\"31420453\", \"30902986\", \"31553907\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural autoinhibition mechanism still not solved at atomic level\", \"How peripheral activation bands are spatially restricted unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Connected disease-relevant transcriptional, translational, and kinase inputs (NEK9, HUNK, KRAS promoter control, m6A/YTHDF1) to GEF-H1-RhoA in cancer and metabolic stress.\",\n      \"evidence\": \"In vitro kinase assays (NEK9, HUNK Ser645), m6A-MeRIP/RIP-seq with knockout mouse, KRAS promoter dissection, and macropinocytosis assays\",\n      \"pmids\": [\"33500736\", \"37193711\", \"34968454\", \"27835861\", \"33653692\", \"26152517\", \"32789168\", \"32692911\", \"33508040\", \"25738744\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Integration of transcriptional, translational, and post-translational control into one quantitative model lacking\", \"Tissue-specific dominance of each regulatory axis unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Validated GEF-H1's autoregulatory C-terminus as a druggable target, blocking RhoA binding to suppress fibrosis, barrier disruption, and vascular leakage in vivo.\",\n      \"evidence\": \"In silico-designed peptide inhibitors with in vitro binding and in vivo retinal disease model\",\n      \"pmids\": [\"35681428\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Tool-compound specificity and pharmacokinetics not fully characterized\", \"Selectivity over other RhoGEFs not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A unified structural and quantitative model explaining how a single GEF integrates microtubule state, dozens of phosphorylation events, competing sequestering partners, and adaptor functions to select between RhoA, Rac, RhoB, and non-catalytic outputs remains to be built.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No atomic structure of full-length autoinhibited or activated GEF-H1\", \"Rules governing GTPase-output selection per stimulus undefined\", \"Hierarchy and crosstalk among regulatory inputs unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005085\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [2, 4, 49]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [7, 32]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [13, 10]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 57]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 14, 40]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [16, 27, 35, 51]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [10, 13, 48]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [48, 54, 37]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [31, 43]}\n    ],\n    \"complexes\": [\n      \"NOD2-RIP2 signaling complex\",\n      \"exocyst (via Sec5)\",\n      \"PP2A-KSR-1 adaptor complex\",\n      \"AMPA receptor complex\"\n    ],\n    \"partners\": [\n      \"RhoA\",\n      \"Rac1\",\n      \"Tctex-1/DYNLT1\",\n      \"14-3-3\",\n      \"cingulin\",\n      \"Sec5\",\n      \"NOD1\",\n      \"RIP2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n\nNote: I used GO:0005085 (guanyl-nucleotide exchange factor activity) for molecular_activity because it is the directly evidenced catalytic role; if that ID is not in the permitted slim, the closest permitted term would be GO:0098772 (molecular function regulator activity), supported by discoveries [#1, #2].","audit_flag":null,"evaluation":{"pairwise":"win"}}